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 A COMPARISON OF CONSUMER-CONTROLLED AND TRADITIONAL HIV COUNSELING 
AND TESTING: IMPLICATIONS FOR SCREENING AND OUTREACH AMONG INJECTION 
DRUG USERS 
 
by 
BRADFORD N. BARTHOLOW 
Under the Direction of Roger Bakeman 
 
ABSTRACT 
 
 
Recent advances in HIV antiretroviral therapy and the availability of prophylaxis for 
opportunistic infections, combined with the opportunity to prevent perinatal HIV infection, 
underscores the value of early diagnosis of HIV infection.  HIV antibody home test kits offer 
individuals the opportunity to collect a blood sample, send it anonymously to a laboratory, and 
receive counseling and referral over the phone.  Home HIV testing may reduce barriers to 
testing that have precluded individuals from learning their HIV serostatus, and if seropositive, 
from taking advantage of efficacious therapeutic and preventive regimens. 
This study employed a randomized-controlled prospective field trial design to determine 
if the availability of home testing increased HIV testing relative to traditional counseling and 
testing among injecting drug users in three HIV prevention/drug treatment contexts; methadone 
maintenance, hospital-based detoxification, and syringe exchange.  Theoretical correlates to 
HIV testing were also evaluated.  Multivariate analyses demonstrated that participants 
randomized to home testing were 2.2 times more likely than those randomized to traditional 
counseling and testing to test for HIV antibodies in this study after controlling for demographic, 
HIV risk, and theoretical variables.  No differences were observed between testing methods with 
regard to obtaining HIV test results.  The relationship between HIV testing and test type was 
 moderated by drug treatment context and history of homeless, with home testing resulting in 
increased testing among methadone participants and persons without a history of 
homelessness.  Analyses of theoretical variables suggested that prevention education stressing 
the benefits of HIV testing, personal risk of HIV infection, and efficacy of available treatments 
could increase HIV testing among injecting drug users.  Participants randomized to home 
testing were more satisfied with testing and telephone-based counseling than were those 
receiving traditional testing and face-to-face counseling. 
Home testing was associated with increased testing perhaps due to reduced barriers to 
testing.  To further reduce barriers to testing and to increase testing among injecting drug users, 
consideration should be given to incorporating oral fluid testing and rapid result capability in 
home test kits.  Counseling could be made available as needed, delivered by telephone, and 
contingent upon the volitional control of the testing consumer. 
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CHAPTER 1 
HISTORICAL PERSPECTIVE 
In 1985, HIV antibody testing first became available in publicly funded “alternate test 
sites” to allow persons to determine their infection status without having to donate blood, thus, 
the original intent of testing was to protect the blood supply (Peterman, Todd, & Mupanduki, 
1996).  In 1987, however, an interest in helping uninfected individuals reduce their HIV risk, and 
in assisting HIV seropositive individuals from infecting others prompted the Centers for Disease 
Control and Prevention (CDC) to rename these testing sites to  “HIV counseling and testing 
(CT) sites” (Peterman et al., 1996).  The secondary prevention implications of early HIV 
diagnosis became more salient after the beneficial effects of treating asymptomatic HIV 
seropositive patients with AZT were reported in 1990.  Since then, HIV CT has become the 
cornerstone of primary and secondary prevention efforts in the United States (Cates, Jr. & 
Handsfield, 1988; Higgins et al., 1991; Peterman et al., 1996; Phillips, Flatt, Morrison, & Coates, 
1995), with the CDC increasing expenditures from 9.8 to 116.2 million dollars between 1985 and 
1994. 
Evidence as to the effects of CT on reducing HIV risk behavior has been mixed (Higgins 
et al., 1991).  Sampling biases, cohort effects, lack of adequate contrast groups, and 
measurement error, have all contributed to ambiguous results reported in the literature (Cates, 
Jr. et al., 1988).  Among 11 early studies of CT targeting injection drug users (IDUs) reviewed 
by Higgins et al., several found no effect related to CT, some improved needle hygiene behavior 
for all groups regardless of CT, one reported increased HIV risk behavior among those receiving 
CT, and another detected a reduction in HIV risk after CT which was not sustained at follow-up 
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(Higgins et al., 1991).   These authors concluded that behavioral change in these studies could 
not be attributed to learning ones’ HIV status. 
More recent studies have reported beneficial public health outcomes associated with CT.   
Women enrolled in a prospective study recruited from four Connecticut community health clinics 
were more likely to initiate safer sex behavior if they had received CT (Higgins et al., 1991; 
Morrill, Ickovics, Golubchikov, Beren, & Rodin, 1996).  Knowledge of one’s positive HIV 
serostatus has been associated with admission to drug treatment programs (McCusker et al., 
1994),  and among IDUs enrolled in a study in Bangkok, CT was associated with increased use 
of condoms and contraception with primary sex partners (Vanichseni et al., 1992).  In 
methadone maintenance programs, CT has been associated with less persistent illicit drug use 
(Farley, Cartter, Wassell, & Hadler, 1992), and in a randomized-controlled trial of out-of-
treatment IDUs and crack users, CT was found to be associated with a reduction in both the 
number of sex partners and the exchange of sex for money or drugs (Haiou, Stark, Weir, & 
Gould, 1996). 
Opportunities for secondary prevention and the prevention of perinatal HIV infection 
further underscore the value of early diagnosis of HIV infection.  Increasingly efficacious early 
antiretroviral therapy (Ho, 1995) and antibiotic prophylaxis for opportunistic infections (Kaplan, 
Masur, & Holmes, 2002), can now improve the health status of HIV-infected persons receiving 
such therapies.  Furthermore, knowledge of positive HIV serostatus among pregnant women 
now offers the opportunity to reduce perinatal infection by offer prophylaxis during labor and 
delivery (Peckham & Gibb, 1995).  Thus, in addition to the important primary prevention goals of 
behavioral risk reduction, the increasing efficacy of secondary prevention strategies further 
reinforces the potential public health value of an early HIV diagnosis.  HIV CT has been 
conceptualized by the World Health Organization’s UNAIDS program (Joint United Nations 
Programme on HIV/AIDS, 2002) as an entry point for HIV prevention and care (Figure 1). 
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Figure 1.  Counseling and testing as an entry point for HIV prevention and care 
MISSED OPPORTUNITIES OF TRADITIONAL COUNSELING & TESTING 
There is evidence, however, that many persons at-risk of infection have not been tested 
(Anderson, Hardy, Cahill, & Aral, 1992).  For example, among clients participating in the New 
Haven Needle Exchange Program between 1990 and 1992,  less than half had previously been 
tested, although 68% had recently seen a health care provider (Rebchook, Guilfoile, & 
Lenaway, 1996).   Similarly, a Colorado needle exchange program reported that only 55% of 
their clients had previously been tested for HIV antibodies (Rebchook et al., 1996).   Among 
patients enrolled in a study evaluating missed opportunities for CT in a high HIV prevalence 
South Bronx community, 51% had not previously received CT (Weber et al., 1996). 
Of at-risk individuals who do seek testing, many are motivated to do so because of 
physical symptoms related to HIV disease (Wortley et al., 1995).  This dynamic has been 
observed among IDUs who upon becoming ill, were tested for HIV antibodies primarily in 
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hospital settings (Wortley et al., 1995).  The CDC reports that 51% of drug using individuals first 
test positive for HIV within one year of receiving an AIDS diagnosis,   and approximately a third 
of persons first testing positive do so within 2 months of an AIDS diagnosis (Wortley et al., 
1995). 
A variety of barriers to HIV testing have been cited in the literature, including denial of 
HIV risk, lack of awareness of the availability of testing services, concerns regarding  
confidentiality, the possibility of discrimination and loss of health insurance, fear of positive 
results, and a perception that there is no benefit from knowing ones’ status (Myers, Orr, Locker, 
& Jackson, 1993; Lyter, Valdiserri, Kingsley, Amoroso, & Rinaldo, Jr., 1987).  When asked  if 
they might go to a neighborhood health center for HIV testing, participants in a CDC-sponsored 
qualitative study often provided confidentiality-related examples for avoiding HIV testing such as 
(Centers for Disease Control and Prevention, 1996):  
“Nobody wants to go down there.  People don’t want you to see them walking in 
and out of there.” 
“...well, me myself I don’t think that I would like going to a neighborhood health 
center because you’re going to where you live at, you are going to see some of the 
same people you live with...”  
  “... I would go out of state, out of town, you know, until it had to be a final or a 
recent thing where I would – couldn’t travel, probably get sick because I may be sick, 
you know, and then I would probably make it a local...” 
 
In addition to these barriers, those who do get tested for HIV antibodies often don’t 
return for their test results.   Reports on CT in publicly funded US sites indicate that of the 4.9 
million tests performed in 1993 and 1994, only 58% of individuals returned for post-test 
counseling (U.S.Department of Health and Human Services, 1996).  Similarly, 1996 data show 
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differences in return rates for HIV test results by site, ranging from 44% in private medical clinics 
to 82% in HIV CT specific sites.  The proportion of individuals testing at drug treatment centers 
who returned for their test results during this time was 69%.  Return for HIV test results also 
varied widely by race with 52% of Blacks returning for results compared to over 75% for Whites 
and Asians.  A low return rate for African-Americans is of concern given their overrepresentation 
among HIV infected individuals.   
These factors suggest that improvements could be made in the CT system, such that 
persons engaging in high-risk behavior would have a greater likelihood of getting tested and 
learning their test results.  Such improvements would enhance the opportunity for individuals to 
make informed decisions based on the knowledge of their antibody status, to change behaviors 
that put themselves and others at risk of infection, and to obtain early medical care if HIV 
infected (Phillips & Coates, 1995).  These realizations along with the recent Food and Drug 
Administration (FDA) approval of a rapid HIV test in the United States, has resulted in the CDC 
initiating new strategies for HIV prevention targeting HIV infected persons that include reducing 
barriers to HIV testing, increasing testing and early diagnosis among persons at-risk of HIV 
infection, and providing treatment for HIV infected persons (CDC, 2003). 
THEORETICAL CORRELATES OF HIV TESTING 
An evaluation of alternative HIV counseling and testing strategies should be theoretically 
grounded in order to facilitate the development and testing of hypotheses related to testing.  
Furthermore, the application of theory may suggest program refinements that could increase the 
likelihood of at-risk individuals getting testing for HIV antibodies, learning their antibody status, 
and if appropriate, commencing therapeutic regimens in a timely and optimal manner.  Finally, 
available theories may facilitate the interpretation of data and suggest areas for future research. 
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Many theories have been employed to facilitate the understanding of HIV risk behavior 
and to guide the development of HIV-related primary and secondary prevention programs, 
including the Health Belief Model (Hochbaum, 1958; Rosenstock, 1974), the Theories of 
Reasoned Action (Ajzen & Fishbein, 1980; Fishbein & Ajzen, 1975) and Planned Behavior 
(Ajzen, 1985), the Transtheoretical Model of Health Behavior Change (Prochaska & Velicer, 
1997), and Empowerment Theory (Rappaport, 1981; Rappaport, 1984).  For this study, 
Empowerment theory and the general principles of community psychology (Florin & 
Wandersman, 1990) provided process-related direction (e.g., for developing collaborative 
partnerships with target community and key stakeholders), the Transtheoretical Model offered 
an organizing schema to frame and guide statistical analyses, the Health Belief Model and the 
Theories of Reasoned Action and Planned Behavior proffered individual-level constructs 
potentially useful for understanding HIV testing behavior and for informing the development of 
improved HIV testing services. 
Empowerment Theory 
Empowerment has been described as the process by which heretofore silent, isolated, 
or marginalized people are provided opportunities to control their own destiny and influence 
decisions that affect their lives (Rappaport, 1981).  Empowerment suggests a distinct approach 
of developing interventions and creating social change (Zimmerman, 2000) and directs attention 
toward health, adaptation, competence, and natural helping systems.    An empowerment 
perspective assumes that many social problems exist due to unequal distribution of and access 
to resources.  Empowerment theory includes both a focus on process and on outcome and is 
context and population specific, thus, it takes different forms for different people in different 
contexts (Zimmerman, 2000). 
7 
 
The empowerment perspective is consistent with the theme of consumer-controlled HIV 
testing.  That is, CCT provides an opportunity for individuals to initiate testing on their own and 
to learn their results if they choose.  Further, the notion of CCT embraces the competence of 
individuals to be able to follow the instructions included with a self-testing kit, obtain an 
adequate biologic sample for testing, have the psychological resilience to cope with a HIV 
seropostive test result, and choose to seek counseling if they feel the need.  CCT also is 
consistent with empowerment in that it offers new behavioral choices to people who may lack an 
intention to change their behavior. 
Early objections to consumer-controlled HIV testing were perhaps inconsistent with the 
values of empowerment and community psychology.  Initially, there was unanimous opposition 
to CCT by the CDC, the American Medical Association, and the Gay Community (Phillips et al., 
1995).  Many concerns regarding the technology and implications for home testing were 
expressed about the specificity and sensitivity of a test using consumer-collected specimens, 
the provision of adequate and ethical pre- and post-test counseling, the possibility of adverse 
psychological impact for individuals testing positive, confidentiality concerns, and fears of test 
abuse (Phillips et al., 1995).   Similar concerns had also previously been expressed about home 
pregnancy testing for women and even clinic-based HIV testing.  There has now been a shift in 
attitude with regard to home testing and CDC has withdrawn its opposition and has issued a 
statement in support of CCT.  However the FDA has not approved HIV test kits for home-use 
which would allow consumers to purchase a test kit, collect a sample in private, and determine 
their own HIV test results within minutes. The Federal Trade Commission has also warned that 
some home-use HIV test kits, many of which are available on the Internet and in the "gray" 
market (i.e., unauthorized imports), supply inaccurate results (Federal Trade Commission, 
2001). 
8 
 
An empowerment orientation also suggests that community members should have an 
active role in establishing the agenda for, and the implementation of, community projects and 
research studies (Zimmerman, 2000).  This study was guided using an empowerment 
framework.  Community forums were conducted to educate and garner input from community 
members.  A community advisory board comprised of members of the substance using target 
populations provided useful guidance for protocol development and implementation.   Finally, 
planning sessions with key stakeholders including government officials, university partners, 
program managers, industry partners, and consumers of needle exchange, detoxification, and 
methadone maintenance services helped ensure community participation, endorsement, and 
study integrity. 
Transtheoretical Model 
Prochaska’s transtheoretical model was developed in the context of psychotherapy for 
substance users and asserts that lasting behavior change is preceded by a process of 
incremental movement through cognitive and behavioral stages (Prochaska et al., 1994). The 
transtheoretical model defines six stages through which a person moves before consistently 
adopting new behaviors; precontemplation, contemplation, preparation, action, maintenance, 
and termination (Prochaska et al., 1997).  
Precontemplators have not yet begun to perceive a behavior as a problem and are not 
consciously evaluating their behavior(s) with a view toward change (Montoya, 1997).  
Contemplators have begun a process of “decisional balance,” evaluating the “pros” and “cons” 
involved with making a behavior change.  For individuals in the preparation stage, the pros 
begin to outweigh the cons, however, these individuals continue to evaluate the implications of 
behavior change and have not yet decided to enact change.  Because individuals in the 
preparation stage may experiment with a behavior, increasing self-efficacy is considered as 
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important as decisional balance for moving to the action stage. In the action stage doubts about 
the benefits of a behavior change have generally been resolved and the new behavior is 
implemented on a consistent basis.  The maintenance stage is characterized by a mastery of 
the skills required to consistently perform a behavior, and at this stage an individual’s behavior 
is considered to have changed. 
Stage models have been considered useful for suggesting important “markers” in the 
change process (Catania, Kegeles, & Coates, 1990b).  In both applied and intervention studies, 
stage-matched interventions have been associated with greater intervention efficacy and study 
retention (Prochaska et al., 1997), as well as increased treatment utilization (Ockene & Ockene, 
1988).   Furthermore, it has been suggested that the failure of interventions to demonstrate 
greater efficacy may be because only a small percentage of persons are in the action stage at a 
given point in time and these individuals are those most likely to change (Prochaska, 
DiClemente, & Norcross, 1992).  Individuals in the stages preceding action may benefit from 
interventions; however, the benefit is likely to be movement from one stage to the next rather 
than actual behavior change.  In this study, the transtheoretical model will be used to stage 
participants regarding HIV testing.  The analysis will take stage into account when evaluating 
the primary outcome variables.  The hypothesis related to stage will be that study participants in 
the action and maintenance stages will be more likely to test for HIV antibodies and return for 
their test results than participants in the precontemplation, contemplation, and ready for action 
stages. 
The Health Belief Model 
The Health Belief Model (Hochbaum, 1958) may be one of the most widely used 
theories of health protective behavior (Weinstein, 1993; Dorr, Krueckeberg, Strathman, & Wood, 
1999) and has been applied in studies of HIV risk behavior among MSM, minorities, and 
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women. The Health Belief Model assumes that an individual’s health behavior is related to 
perceived susceptibility to infection, perceived severity of consequences, perceived 
efficaciousness of protective action, and perceived barriers to protective behavior.  In the 
context of HIV testing, the Health Belief Model suggests that individuals who perceive that; they 
are susceptible to HIV infection, HIV disease is severe, it is beneficial to know one’s HIV status, 
and that there are few barriers to HIV testing would be more likely than individuals who do not, 
to test for HIV antibodies and learn their HIV status (Dorr et al., 1999). 
Perceived susceptibility has received the most attention from researchers examining the 
relationship between Health Belief Model variables and HIV testing (Dorr et al., 1999).  Results 
have been mixed depending upon population surveyed.  Surveys of the general population 
(Anderson et al., 1992), gay men (Myers et al., 1993), individuals waiting for mass transit 
(Kalichman & Hunter, ), and gay, lesbian, bisexual youth (Maguen, Armistead, & Kalichman, 
2000), have found that individuals who perceive themselves to be at-risk of contracting HIV are 
more likely to have been tested in the past.  Other studies have not found a relationship 
between HIV testing and HIV risk perception (Lyter et al., 1987; McCusker et al., 1988; Catania, 
Kegeles, & Coates, 1990a). 
Perceived severity has had more limited evaluation with regard to HIV testing (McCusker 
et al., 1988).  Contrary to predictions derived from the Health Belief Model, these authors found 
that men who chose to learn their HIV antibody status perceived AIDS as being less severe 
than men who chose not to learn their antibody status.  The authors suggest that this result may 
reflect the fear associated with HIV/AIDS.   
Perceived benefits of HIV testing have consistently been found to be related to HIV 
testing among MSM and include such benefits as changing sexual practices, receiving 
treatment if positive, and to better cope with the fear of AIDS.  Similarly, Dorr et al. (1999) found 
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that among individuals presenting to a student health center, those perceiving greater benefits 
to testing were more likely than those perceiving fewer benefits to have ever tested for HIV.    
Among the most common reasons for declining to learn one’s test results are concerns 
that a positive test result would have negative psychological consequences (Lyter et al., 1987), 
that results would not be useful in changing sexual behavior (Lyter et al., 1987; Zapka, 
Stoddard, Zorn, McCusker, & Mayer, 1991), that knowledge of serostatus is not useful because 
there are not effective treatments (Zapka et al., 1991) and that test results are not predictive of 
progression to AIDS (Lyter et al., 1987).  Given the more recent success of antiretroviral therapy 
in preventing progression to AIDS, the perception that treatments are ineffective may have 
diminished as a barrier to testing.  In fact, perceptions of treatment efficacy have been 
implicated as a potential explanation for both upward trends of HIV risk behavior since 1996, as 
well as recent outbreaks of sexually transmitted bacterial infections (Scheer, Chu, Klausner, 
Katz, & Schwarcz, 2001; Centers for Disease Control and Prevention, 1999a; Centers for 
Disease Control and Prevention, 1999b; Fox et al., 2001).   
The Theories of Reasoned Action and Planned Behavior 
Two closely related theories applied widely in HIV research, are the Theories of 
Reasoned Action (Fishbein et al., 1975)  and Planned Behavior (Ajzen et al., 1980; Ajzen, 
1985).   These expectancy-value models dominated motivational psychology for some time 
(Kuhl, 1982).  In these models, the person intends to perform an action based upon the 
expectancy for achieving a goal and the extent to which a person values that goal (Kuhl, 1982).  
The Theory of Reasoned Action (TRA) is based on the assumption that people consider 
available information and the implications of their actions (Fishbein et al., 1975).  The theory 
further assumes that a person’s intention to perform a behavior is the immediate determinant of 
action.  According to the TRA, two factors determine a person’s intention; the person’s attitude 
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toward the behavior (i.e., the individual’s positive or negative evaluation of performing a 
behavior), and subjective norms (i.e., the person’s perception of social pressures to perform a 
behavior) (Fishbein et al., 1975).  In the TPB, three factors determine a person’s intention; the 
person’s attitude toward the behavior, subjective norms, and the degree to which a person feels 
that they can successfully perform the behavior (Ajzen et al., 1980; Ajzen, 1985). 
Jemmott & Jemmott (1991) for example, used the TRA as a conceptual framework to 
evaluate condom use among African-American women.  In this study, a woman’s use of 
condoms was hypothesized to be a function of her intention to use condoms.  Intentions to use 
condoms were assumed to be a function of attitudes (positive or negative) toward using 
condoms, and perceptions of what significant others think a woman should do with regard to 
condom use.  Thus, if a woman believed that using condoms would protect her from HIV 
infection and that protection was desirable, her attitude toward using condoms should have 
been positive.   Furthermore, beliefs that a woman’s friends would approve of condom use, and 
that the opinions of friends were important, would also be predictive of intentions to use 
condoms.  These authors found that both positive attitudes toward condom use and perceived 
subjective norms predicted intentions to use condoms. 
In the context of HIV testing, the constructs offered by the theories of Planned Behavior 
and Reasoned Action may be similarly applied.  That is, individuals who perceive HIV testing to 
be desirable and beneficial, and that their friends would approve of testing, would be expected 
to have stronger intentions to test for HIV than those who do not.  Desirability and benefit may 
be related to feeling as though one is being proactive with regard to their health and that 
effective treatments are available for those who do test HIV positive.   Perceived social norms 
regarding HIV testing may be associated with the perceived attitudes of sexual partners and 
personal friends, as well as the potential for negative social consequences (e.g., stigmatization) 
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of having HIV.   These constructs overlap with Health Belief Model variables of treatment 
efficacy and subjective norms.   
Theoretical “Consensus”  
An early theorist workshop addressing HIV risk behavior that included Albert Bandura 
(Social Learning Theory), Martin Fishbein (Theory of Reasoned Action), Marshall Becker (The 
Health Belief Model), Harry Triandis (Theory of Subjective Culture and Interpersonal Relations), 
and Fredric Kanfer (Theory of Self-Regulation and Self-Control) was conducted in October 
1991.  Together, these five theories represented almost all of the variables that had been 
utilized in attempts to understand and change a wide variety of behavior.  The goal of this 
workshop was to identify a finite set of variables that should be considered in any behavioral 
analysis.  These theorists combined the common elements of their theories into a “consensus 
theory” (Fishbein et al., 1991) that focused on an individual’s intention to change behavior.  
Eight variables were identified as critical for understanding behavior: intention, environmental 
constraints, ability, anticipated outcomes (or attitude); norms, self-standards, emotion, and self-
efficacy.  Of these, intention, environmental constraints and personal skills were considered 
necessary and sufficient for producing any behavior.  The remaining variables were viewed as 
influencing the strength and direction of intention. 
In a comparative theoretical paper, Weinstein (1993) states that the real goal should not 
be to decide which theory is best, but to decide which variables and processes improve our 
understanding of health-protective behavior.  Finding that one theory correlates .4 with observed 
behavior and that another correlates .5 is not nearly as helpful as discovering what features of 
the theories account for their difference.  Weinstein suggests that in addition to examining the 
overall prediction of behavior, an attempt should be made to understand the relations among 
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the independent variables and the behavior claimed by the theory to match the relationships 
actually observed. 
In this study, the theories described provided an organizing structure for the 
development of the project, its conduct, and data analyses.  Empowerment theory and the 
general principles of community psychology guided the process of study design and 
implementation, the Transtheoretical Model offered an organizing schema to frame and guide 
statistical analyses, the Health Belief Model, and the Theories of Reasoned Action and Planned 
Behavior suggested individual-level constructs useful for understanding HIV testing behavior 
and the potential use of home testing technology for the detection of HIV antibodies. 
HOME TESTING TECHNOLOGY - CONSUMER-CONTROLLED TESTING 
Technological advances in HIV antibody testing have eliminated the need for venous 
blood collection and have made possible consumer-collected specimens which then are mailed 
in for laboratory testing (Gwinn, Redus, Granade, Hannon, & George, 1992; Hannon, Lewis, 
Jones, & Powell, 1989).  Test results and medically directed risk-reduction counseling may then 
be obtained via telephone (Bayer, Stryker, & Smith, 1995; Home Access Health Corporation, 
2003). 
A demand for CCT was indicated by a 1992 Health Interview Survey which showed that 
42% of individuals at-risk of HIV infection said that they would be likely to use home tests; and 
of this group, 63% had not been previously tested (Anderson et al., 1992).  Respondents in this 
survey were more interested in CCT if they were; male, younger, nonwhite, lower income, at 
increased risk for HIV, or perceived themselves to be at-risk of infection.  Furthermore, Blacks 
and Hispanics were more likely than other racial/ethnic groups to say that they would be likely to 
utilize home testing.  This study did not indicate how cost, distribution, or methods for obtaining 
results might influence the willingness to use home testing. 
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The market price for home testing kits is $50, which may be cost-prohibitive for 
marginalized and stigmatized individuals at-risk of HIV infection, such as, IDUs.  With cost as a 
potential barrier to testing, the goal of increased access to HIV testing for persons most at risk 
of infection may not be realized (Janssen et al., 2001).  Consequently, incorporating CCT 
technology within the context of existing HIV risk reduction and outreach programs could 
increase access to testing for high-risk individuals, increase the likelihood that individuals will 
learn their HIV serostatus, and if infected, receive early antiretroviral therapy and antibiotic 
prophylaxis for opportunistic infections. 
THE RESEARCH CONTEXT IN PHILADELPHIA  
Philadelphia provided an excellent opportunity for evaluating the public health benefits of 
CCT due to the social and epidemiologic characteristics of the city, as well as the existing HIV 
and drug abuse prevention and research infrastructures.  Of all positive HIV tests performed at 
publicly funded CT sites in 1994, Philadelphia ranked seventh in HIV prevalence (3.2%), just 
behind New York and New Jersey (Fife & Mode, 1992a; Fife & Mode, 1992b).  Between 1988 
and 1990, the annual estimated AIDS incidence and prevalence per 100,000 people in 
Philadelphia increased by 21% and 62% respectively, and AIDS prevalence shifted during this 
time toward lower income census tracts and was estimated to increase by 113% in poor 
neighborhoods (Fife et al., 1992a; Fife et al., 1992b).  In 1994, IDUs became the risk group with 
the highest proportion of newly diagnosed AIDS cases for the first time in Philadelphia (City of 
Philadelphia Department of Health, 1994).  More recently, the number of IDUs in Philadelphia 
has been estimated to be 45,260 and HIV incidence among this group has been estimated at 
3% per 100 person years (Holmberg, 1996). 
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CHAPTER 2 
METHODS 
Study Design 
The study employed a randomized prospective field trial design that included both an 
initial and a one-month follow-up interview.  Testing outcomes (HIV testing and obtaining test 
results) were compared between TCT and CCT, and across three drug abuse 
prevention/treatment programs; (1) in-treatment methadone maintenance, (2) transitional 
hospital-based drug detoxification, and (3) out-of-treatment syringe exchange.  Theoretical 
variables potentially related to HIV testing were assessed. 
Study Objectives: 
1. To compare the likelihood of HIV testing and obtaining test results between participants 
randomized to TCT and CCT among methadone maintenance, detoxification, and out-of-
treatment drug users 
2. To identify sociodemographic, psychosocial, behavioral, and theoretical factors related 
to HIV testing and obtaining HIV test results 
3. To compare satisfaction with the HIV testing process between participants randomized 
to traditional counseling and testing and consumer-controlled testing  
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Selection of Study Sites 
The social, demographic, and behavioral characteristics of drug users can vary greatly 
across prevention and treatment environments.  For example, out-of-treatment IDUs targeted by 
HIV prevention outreach programs (e.g., syringe exchange programs) may differ in terms of 
demographics, HIV risk, and social and behavioral stability from drug users in other 
environments.  Thus, evaluating CCT in a variety of drug prevention and treatment 
environments will provide a broader perspective as to the determinants of HIV testing and how 
CCT might be incorporated into HIV and drug abuse prevention and treatment programs.  Three 
study sites serving different segments of the drug use/treatment population; out-of-treatment 
drug users, methadone patients, and drug detoxification patients participated in the study.   
Sites were selected by working closely with the Philadelphia Department of Health, Coordinating 
Office of Drug and Alcohol Abuse Programs (CODAAP). 
In 1993, CODAAP received funding to deliver HIV-related services to substance abusers 
in treatment.  These funds supported the development of the “Early Intervention Program” 
intended to provide HIV prevention counseling, testing, and primary health care services to 
substance abusers.  The Early Intervention Program is comprised of two major elements: on-
site HIV pre- and post-test counseling services, and the provision of HIV primary health care.  
Nineteen (19) testing sites were funded in 1995, which conducted 6,851 pretest counseling 
sessions, 5,059 HIV antibody tests, and 3,308 post-test counseling sessions.  One hundred and 
ninety-nine (199) individuals tested HIV seropositive, indicating an HIV seroprevalence of 3.9%.  
Of those individuals tested, 65% received post-test counseling (City of Philadelphia, 1996).  
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Because of CODAAP’s commitment to developing and maintaining a model program of 
HIV prevention counseling, testing, and primary health care for substance abusers, and 
because many drug users are unwilling to be tested in traditional clinic-based settings, 
collaboration with CODAAP strengthened this study and at the same time provided the 
opportunity to broaden access to HIV testing and counseling for individuals at-risk of HIV 
infection, and access to treatment for HIV-infected individuals.   The following criteria were used 
during the site selection process: 
1. the willingness of the program to participate in the study and to fulfill the requirements of 
the study protocol; 
2. the capacity of the program to accommodate the logistical needs of the study protocol, 
3. sufficient client census to recruit study participants with the appropriate demographic 
characteristics, 
4. no mandate of CT as a condition of drug treatment. 
 
Three sites were selected based upon these criteria: Prevention Point Philadelphia, 
Kensington Hospital, and North Philadelphia Health Systems.  Prevention Point Philadelphia 
enrolled out-of-treatment participants from syringe exchange sites, Kensington Hospital enrolled 
participants from a hospital-based drug detoxification program, and North Philadelphia Health 
Systems enrolled participants from a methadone program. 
Out-of-Treatment Drug Users - Prevention Point Philadelphia  
Prevention Point Philadelphia (PPP) is a syringe exchange program that has been 
operating in North Philadelphia since 1991.  PPP’s mission is to protect the health of habitual 
drug users and sex industry workers and to prevent the spread of HIV through syringe sharing.  
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PPP has an empowerment philosophy stressing that the rights of people with addictions 
includes the ability to protect their own health and the health of their sexual partners and loved 
ones.  PPP offers referrals for drug treatment, HIV testing, and comprehensive health care. 
At the time of this study, PPP offered mobile van-based needle exchange services at 
five sites in Philadelphia.  The ethnic composition of PPP’s clients was 45% White, 45% African-
American, and 10% Latino.  “Exchangers” using the program varied widely in age, economic 
status, and frequency of drug use.  In 1994, PPP distributed approximately 750,000 sterile 
syringes.  In addition, PPP conducts shooting gallery outreach and operates a harm reduction 
“drop-in” center that provides referrals to social, medical, and drug treatment services; offers 
support groups and educational forums; and has a medical clinic.  
Detoxification Participants - Kensington Hospital 
Kensington Hospital is a non-government, not-for-profit, neighborhood hospital 
established in 1887 to serve the needs of women. The hospital is located in a working class 
neighborhood in north Philadelphia, where many parts of this community are now experiencing 
severe economic distress.  Once a thriving manufacturing area of the city, few factories remain 
and unemployment rates are high.  The hospital prides itself on being responsive to the needs 
of the community and because of the high prevalence of substance abuse in the neighborhood, 
now provides both drug and alcohol detoxification services.   
The hospital has 45 inpatient beds, and in 1995 had 2,334 inpatient admissions, and 
15,732 outpatient visits.  In 1995, 1,831 HIV pre-test counseling sessions were conducted at 
Kensington Hospital, with 1,002 (55%) of the pre-test counseled patients actually getting tested 
for HIV.  Two hundred and eighty-nine (289; 29%) of the patients tested for HIV returned for 
post-test counseling and received their HIV test results.  Of all HIV tests conducted at 
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Kensington Hospital in 1995, 48 (5%) were positive for HIV antibodies.          
In-Treatment Drug Users - North Philadelphia Health Systems 
North Philadelphia Health Systems (NPHS) is the largest methadone program in the 
state of Philadelphia.  Over 600 individuals are enrolled in the methadone program.  In addition 
to the outpatient methadone program, NPHS has 100 individuals enrolled in drug-free outpatient 
treatment, and 200 individuals enrolled in intensive outpatient treatment. 
In 1995, NPHS/Girard Medical Center conducted 842 HIV pre-test counseling sessions, 
with 747 (89%) of the pre-test counseled patients choosing to get tested for HIV antibodies.  Of 
these 747 individuals, 404 (54%) returned for post-test counseling and received their HIV test 
results.  Of all HIV tests conducted at Girard Medical Center in 1995, 38 (5%) tested positive for 
HIV antibodies. 
Participants and Eligibility Criteria 
Each of the three study sites set enrollment targets of approximately 200 participants, 
with the intent to randomly assign 100 individuals to TCT and 100 to CCT.  While this number 
was not ideal from the perspective of conducting within-site analyses based upon power 
analyses, the overall power to assess the testing outcomes when controlling for site was 
adequate.   To be eligible for the study an individual had to be at least 18 years of age, have 
never tested positive for HIV antibodies, and have scored below a suicide risk threshold using 
the Beck Hopelessness Scale (Beck, Steer, Kovacs, & Garrison, 1985; Beck, Brown, Berchick, 
Stewart, & Steer, 1990).   Participants provided informed consent and were paid $10.00 for the 
initial interview and $20.00 for the one-month follow-up interview. 
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Instruments 
Brief Screening Instrument 
A brief screening instrument was used to assess interest in HIV testing, study eligibility, 
and willingness to participate in the study.  The screening instrument was self-administered and 
included items regarding basic demographics, drug treatment status, HIV testing history, 
interest in HIV testing, hygienic needle behavior, and HIV sex risk behavior.  Reasons for 
refusal were also recorded. 
Suicide Potential - Beck Hopelessness Scale 
During community forums conducted among members of the target population and 
consultations with HIV health care professionals who deliver post-test counseling, concern was 
expressed about potential suicide among home testers who learn their HIV seropositive 
antibody status over the telephone.  Though the risk of suicide related to a de novo HIV positive 
antibody test results appeared to be low, in response to the concerns elicited during community 
forums and consultations, the Beck Hopelessness Scale (Beck et al., 1985; Beck et al., 1990) 
was used to assess suicide potential during the pre-enrollment screening.   The Hopelessness 
Scale is a 20 item true-false self-report instrument which has been found to differentiate among 
suicide threateners, attempters, and controls.  The Hopelessness Scale has three factors and 
an internal consistency of .93 (Kuder-Richardson).  In a 10-year follow-up for eventual suicide, 
the scale showed a 91% sensitivity for inpatients (Beck et al., 1985) and a 3½-year follow-up 
study among outpatients showed a 94% sensitivity (Beck et al., 1990). Potential participants 
who scored a 9 or above on the Hopelessness Scale were not eligible for study participation 
and were referred for psychological services. 
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In this study, participants had access to 24-hour, manufacture provided, phone 
counseling.    Phone counseling is included with the purchase of a test kit.  In addition to these 
manufacture-provided services, participants were able to call study staff as needed. 
HIV Risk Behavior 
The Risk Assessment Battery (RAB) was used as a rapid, private, and minimally 
intrusive method of assessing both drug and sexual HIV risk behavior (Navaline et al., 1994).  
The RAB is a self-administered questionnaire that takes less than 15 minutes to administer, has 
been shown to reliably discriminate between HIV seropositive and seronegative individuals, and 
has acceptable levels of internal and test-retest reliability (Navaline et al., 1994).  In addition to 
the questions included on the RAB, HIV risk questions identical to those asked during the Home 
Access pre-test counseling session were included.  While these additional questions were 
somewhat redundant with the RAB, this information allowed for the possibility of a comparison 
of responses given by participants during a face-to-face versus a telephone counseling session.        
HV Testing & Theory-Based Measures Related to Testing 
All participants completed a face-to-face interview about HIV testing that included 
domains related to past testing experience(s), perceived barriers and benefits to testing, 
intentions for future testing, and preferred modes of testing and receiving results.  Participants 
were asked to describe how they would cope with a positive test result, and where they might 
go for help if they tested positive. 
Measures based upon theoretical constructs from Stage of Change Theory, the Theories 
of Reasoned Action/Planned Behavior, and the Health Belief Model were assessed using factor 
analyses.  Internally and conceptually consistent items were  used to construct summated rating 
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scales reflecting each construct. 
Stages of Change 
The Transtheoretical Model was incorporated so that participants could be categorized 
according to stages of change in relation to HIV testing behavior according to the a priori 
schema presented in Table 1.  Participants classified in the precontemplation stage are not 
aware that HIV tests exist, do not recognize any value to being tested for HIV, and do not 
indicate an intent to test during the next year.   Participants classified in the contemplation stage 
are aware of HIV testing, recognize its potential value, report having seriously thought about 
getting tested, but have not yet made a decision to get tested. In addition to being aware of HIV 
testing and recognizing its value, participants determined to be in the preparation stage express 
an intention to be tested in the very near future (one month), however, have not yet been tested.  
Participants classified in the action stage perceive that HIV testing is important given their risk 
behavior and have been tested at least once in the past six months.  Finally, participants who 
continue to engage in risk behavior and who have been frequently tested over the past three 
years fall within the maintenance stage.  This classification scheme provides a potential context 
against which to evaluate constructs from the Theories of Planned Behavior/Reasoned Action 
and Health Belief Model measures. That is, testing and obtaining one’s HIV test results may be 
more likely among participants who are in the action stage or above. 
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Table 1 
Classification schema for stages of change related to HIV testing 
 
 Intention to be tested in the next:   
Stage Aware 
Recognize 
Value 
One 
Month 
Six 
Months 
Twelve 
Months 
Recent 
Testing 
Frequent 
Testing 
Precontemplation No No (Yes?) No No No No  No 
Contemplation Yes Yes   No, but 
considering 
No No 
Preparation Yes Yes  Yes, 
near 
future 
 No No 
Action Yes Yes, 
important 
given risk 
Yes   Yes, in last 6 
months 
No 
Maintenance Yes Yes, 
continues to 
engage in 
risk behavior 
Yes   Yes Yes, in 
past 3 
years 
 
Theories of Reasoned Action/Planned Behavior 
Items based upon the Theories of Reasoned Action/Planned Behavior addressed 
intentions for testing, attitudes about testing, perceived testing norms and testing self-efficacy.  
The summated rating scales based upon factor and reliability analyses are presented in 
Appendix A. 
The Health Belief Model 
Questions based upon the Health Belief Model were included addressing perceived 
susceptibility to HIV infection, severity of consequences, efficaciousness of protective actions 
(i.e., early intervention), barriers to testing, and cues to action. The summated rating scales 
based upon factor and reliability analyses are presented in Appendix A. 
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Follow-up Interview 
Participants were scheduled for a one-month follow-up interview at the time of their initial 
interview.  The follow-up interview included questions about pre-test counseling, HIV testing, 
post-test counseling, HIV risk behavior, satisfaction with the testing and counseling procedures, 
adverse reactions, intentions for future testing, and preferred modes of testing in the future.  If a 
participant had not completed HIV pre- and post-test counseling by the time they were 
contacted for their one-month follow-up, they were rescheduled for their follow-up interview at 
two months from the date of their initial interview.  If at two months they had not completed the 
testing process, they were interviewed using the standard follow-up interview.  This procedure 
was intended to allow those participants who intended but delayed HIV testing to complete the 
testing process and to receive their HIV test results.  If participants did not complete a testing 
phase (i.e., pre-test, testing, post-test, referral follow-up) information was gathered about the 
reasons for noncompletion.  The RAB was also administered at the follow-up interview to 
evaluate the relationship of HIV risk behavior to HIV testing outcomes. 
Procedures 
As a client presented to a study site, they were asked if they had an interest in HIV 
testing.  If interested, a study staff person provided them with a description of the study and 
obtained basic demographic and HIV risk information.  If the individual was not interested in 
study participation, the reason for refusal was recorded and they were referred to a HIV 
counseling and testing site. 
Individuals who were interested in enrolling were screened for eligibility, and suicide 
potential was assessed using the Beck Hopelessness Scale.  Individuals scoring above a 9 on 
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the Beck Hopelessness scale were counseled by the study staff and referred to psychological 
services.  Individuals who were not eligible to participate were referred to local agencies that 
provide HIV CT services. 
Informed consent was obtained from all participants prior to enrolling in the study.  After 
consent was obtained, face-to-face interviews were conducted.  If an interviewer was 
unavailable at the time of enrollment, an appointment was made for a future interview in a 
convenient and safe location, and the participant was given an appointment card.  Locator 
information was obtained from participants, and included address and phone number if 
available, name and phone number of three friends, and two places where the individual might 
‘hang out’ or spend a significant amount of time.  This type of locator information had previously 
been successfully used to maintain high retention rates in cohort studies targeting similar 
populations.  
Randomization to CT or CCT Conditions 
After the interview, the study staff opened a coded envelope indicating the random 
assignment of the participant to either the TCT or CCT conditions.  Participants randomized to 
the TCT condition were referred to a confidential testing site, or if testing was provided in-house 
(i.e., detoxification program), a referral was made to the in-house HIV testing staff.  A release of 
information form was obtained from the participant allowing the study staff to obtain the HIV 
testing information from the TCT site to which the participant was referred.   Participants 
randomized to the CCT condition received a home test kit (Home Access SystemTM) and 
instructions on using the home collection kit, which included a discussion of contraindications, 
precautionary measures, product limitations, manufacture’s informed consent, registering the 
Home Access code number (necessary for obtaining HIV test results), mailing the specimen, 
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and obtaining the result.  The Home Access code number was recorded in the participant’s 
study record for subsequent retrieval of database records from Home Access.   If desired, all 
participants were able to contact a study staff person for face-to-face counseling, to answer 
questions, or for service referrals.  After these procedures were completed, an appointment was 
scheduled for the follow-up interview and participants were paid $10.   
Follow-up Interview 
At the follow-up visit participants completed a face-to-face interview which included 
questions regarding satisfaction with the testing process to which they were randomized, 
problems they encountered in the testing process, the type of information provided to them 
during pre- and post-test counseling, their intentions for future HIV testing, referrals provided 
and follow-through with these referrals.  In addition to these questions, the RAB was also 
administered. 
After the interview, any questions participants had were addressed and referrals were 
provided as necessary.  Participants were then paid $20.00 for their participation and were 
provided with a phone number to call if they had future questions. 
Data Exchange with Home Access & Confidential CT Sites 
The retrieval of testing data was considered optimal from both the Home Access Health 
Corporation for participants randomized to the CCT and from confidential testing sites for 
participants randomized toTCT.   A signed release of information form authorized study staff to 
receive participant data from Home Access Health Corporation and confidential CT sites.  
These data included demographics and HIV risk behavior information, whether the participant 
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received pre-test counseling, was HIV tested, received post-test counseling and their HIV test 
results.  HIV test results were also obtained. 
Data records from the Home Access Health database were extracted using kit 
identification numbers.  After all follow-up visits were completed; Home Access was sent an 
electronic list of study participant test kit numbers to retrieve the appropriate computerized 
records.  These data records were merged with study interview data.  Data from confidential 
testing sites were retrieved in a similar fashion; however, participant name was used to retrieve 
records at the confidential CT sites.  Immediately after the testing data was obtained from the 
confidential CT sites, the testing data were indexed using study identification number, the name 
identifier was then deleted, and the link between name and study identifier stored in a separate 
locked file cabinet as described in the records management section.  Because it was anticipated 
that these data may not be reliably retrieved from testing sites for multiple reasons, participants 
also self-reported the testing outcome data during their follow-up interview. 
Data Analyses 
Standard bivariate analyses (Chi-square, t-tests, and ANOVA) were used to evaluate 
selection differences among those who enrolled in the study and those who refused to 
participate.  These analyses included comparisons of demographic, sexual and drug-related 
HIV risk, history of sexually transmitted diseases, Beck Hopelessness Scale scores, and HIV 
testing history between study participants and non-participants.  Multivariate logistic regression 
analysis was then conducted to model study enrollment using the correlates identified in the 
bivariate analyses.  This same approach was also used to assess study retention.   
Randomization to TCT and CCT was assessed by comparing these groups across 
demographic, HIV risk, and theoretical factors.  Differences among sites were also evaluated 
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across demographic, sexual and drug-related HIV risk, history of sexually transmitted diseases, 
Beck Hopelessness scores, and HIV testing history to better understand the contextual factors 
associated with treatment context. 
Testing Outcome Analysis 
Subsequent to these analyses of study enrollment, randomization, site differences, and 
retention, bivariate analyses were also conducted to evaluate the association of study site, 
demographic, risk behavior, and theoretical variables to HIV testing outcome variables.  
Variables associated with testing outcomes in these bivariate analyses were retained for 
multivariate logistic regression analyses.  Hierarchical logistic regression was used to evaluate 
the unique effect of testing method above and beyond the effects of study site, demographic, 
and theoretical variables.  For example, to evaluate the effect of testing method on being tested 
for HIV, site and demographic variables were entered in block one, health status variables in 
block two, HIV risk variables in block three, theoretical variables in block four, and testing 
method in block five.  The R2L statistic was calculated for each block of variables indicating the 
magnitude of the effect for the block relative to the base model.  R2L is an analog to ∆R2 in 
multiple regression analysis.  The unadjusted and adjusted odds ratios were calculated for the 
bivariate and multivariate analyses respectively. 
Records Management 
Since participants were interviewed on more than one occasion, it was necessary to 
maintain data that permitted site researcher staff to contact participants.  All participant locater 
data was stored in secure areas and in a locked file cabinets.  Access to the locked files 
containing locator data was limited to the site coordinator, projected coordinator, and principle 
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investigator.  Computerized and hard copy locator data was kept separate from interview and 
HIV test data, which were indexed by study identifier code only. 
Human Subjects 
Written ethical approval was obtained from Institutional Review Boards at the Centers for 
Disease Control and Prevention, the University of Pennsylvania, and the City of Philadelphia’s 
Department of Public Health.  This research involved the completion of interviews from 
individuals who are members of the injection drug using community.  Individuals who were 
interviewed were fully informed of the purpose of the study, and the potential risks.  The consent 
and release of information form(s) were approved by appropriate IRBs prior to use.  
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CHAPTER 3 
RESULTS 
SCREENING AND ENROLLMENT 
Overall, 645 individuals were screened for study participation.  Of these, 532 (83%) were 
eligible to enroll in the study based upon the Beck Hopelessness Scale eligibility criteria.  Of the 
532 eligible individuals, 489 (92%) enrolled in the study. 
Participants were more likely to be enrolled from the Kensington Detoxification Hospital 
program than from the other sites, and approximately three quarters of participants were male 
(Table 2).  Those enrolled were primarily African American and Caucasian, and most 
participants had a high school education or less.  Almost half of the participants reported their 
primary source of income to be Welfare, over 80% reported an annual income of less than 
$10,000 per year, and the majority reported Medicaid to be their source of health insurance. 
32 
 
Table 2 
Demographics of Individuals Enrolled in the Study 
 _________________________________________________________ 
     
 Variable  N % M (SD)
 _________________________________________________________ 
 Site 
  Kensington 199 41 
  Prevention Point 128 26 
  ACT 161 33 
 Sex 
  Male 348 71 
  Female 140 29 
 Race 
  African-American 234 48 
  Latino/Hispanic 46 9 
  Caucasian 205 42 
  Other 4 1 
 Education 
  < HS 193 40 
  HS 280 57 
  Any College 15 3 
 Primary Source of Income 
  Full time  48 10 
  Part time 40 8 
  Welfare 219 45 
  Family/friend 19 4 
  Hustling 66 14 
  Other 96 20 
 Income   
  Under $10,000 398 81 
  ≥$10,000 94 19 
 Living Situation 
  Own House 187 39 
  With friend  206 42 
  Rented Room 33 7 
  Homeless 37 8 
  Other 23 5 
 Medical Insurance  
  Private health plan 14 3 
  Medicaid 249 53 
  Social security disability 31 7 
  Medicare 34 7 
  Military 2 .4 
  Other insurance 144 30 
 
 Age 40.4 75.9 
 
 Beck Hopelessness Scale 3.98 3.09 
 _________________________________________________________________ 
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Assessment of Selection Biases 
Differences were observed between those enrolled and not enrolled in the study.  Fewer 
participants than expected were enrolled from the Prevention Point Syringe Exchange Program 
than from the Kensington Detoxification Hospital or the ACT methadone maintenance program 
(Table 3).  African-Americans were more likely to enroll than were persons from other 
racial/ethnic groups.  Individuals who had full-time jobs were more likely to enroll than were 
individuals whose primary source of income was from other sources, whereas those who 
reported “hustling” as their primary source of income were least likely to enroll. 
Persons who enrolled in the study were less likely than those who did not, to report 
injecting drugs in the 6 months prior to study enrollment (Table 4), however, a significant 
majority of those enrolled did report injecting drugs, and thus were at significant risk of HIV 
infection.  Furthermore, almost half on the individuals screened and enrolled in the study 
reported sharing injection equipment with drug using partners, underscoring the risk of HIV 
infection in this population. Study enrollees were less likely non-enrollees to report having been 
diagnosed with hepatitis B/C, further indicating that non-enrollees were at greater drug-related 
risk of HIV infection than were enrollees.  Very few men reported having sex with other men and 
few women reported engaging in anal sex with male partners, indicating that the primary risk of 
HIV in this population was related to injecting drug use.  Most individuals screened for the study 
reported previously being tested for HIV, with no differences in prior testing between those 
enrolled and those who were not. 
34 
 
Table 3 
 
Demographic Differences between Individuals Enrolled and not Enrolled in the Study  
___________________________________________________________________________________ 
   Screening Group 
  _________________________________ 
  Not Enrolled  Enrolled  
Variable  N|M %|SD N|M %|SD  χ2|t p 
Site 
 Kensington 53 34 199 41 14.9 .001
 Prevention Point 66 42 128 26  
 ACT 37 24 161 33  
Sex 
 Male 103 66 348 71 1.6 .21 
 Female 53 34 140 29   
Race 
 African-American 46 30 234 48 16.9 .001 
 Latino/Hispanic 19 12 46 9 
 Caucasian 88 56 205 42 
 Other 3 2 4 1  
Education 
 < HS 65 42 193 40 0.9 .65 
 HS 85 55 280 57 
 Any College 5 3 15 3 
Primary Source of Income 
 Full time  4 3 48 10 17.8 .003 
 Part time 9 6 40 8 
 Welfare 61 40 219 45 
 Family/friend 5 3 19 4 
 Hustling 35 23 66 14 
 Other 40 26 96 20 
Income  
 Under $10,000 136 88 398 81 3.4 .07 ≥ 
$10,000 19 12 94 19   
Living Situation 
 Own House 49 32 187 39 7.6 .11 
 With friend  63 41 206 42   
 Rented Room 13 8 33 7 
 Homeless 22 14 37 8 
 Other 8 5 23 5  
Medical Insurance  
 Private health plan 2 1 14 3  3.43  .64 
 Medicaid 70 48 249 53 
 Social security disability 13 9 31 7 
 Medicare 11 7 34 7 
 Military 0 0 2 0 
 Other insurance 49 34 144 30 
 
Age (Mean,SD, t) 41.5 24.1 40.4 75.9 0.59 .50 
 
Beck Hoplessness Scale 
 (Mean, SD, t) 11.5 4.7 3.98 3.09 1.72 .09 
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Table 4 
HIV Risk Factors and HIV Testing of Individuals Enrolled and not Enrolled  
 
   Screening Group 
  ____________________________ 
  Not enrolled Enrolled 
Risk factor N % N %  χ2 p 
 
Drug Related Risk 
Injected drugs last 6 months 121 77.6 329 67.4  5.78 .016 
Shared (syringe, cooker, 76 48.7 209 42.7  1.71 .191 
cotton, rinse water) 
 
Sexual Risk 
Men reporting sex with malea 1 0.6  4 0.8  0.46 .830 
Women reporting anal sex 0 0.0  5 1.0  1.61 .34 
with male partner a  
 
STDs 
Hepatitis B/C 31 20.0 57 11.7  6.89 .009 
Gonorrhea a 1 0.6  4 0.8  0.46 .830 
Syphilisa  3 1.9  3 0.6  2.22 .14 
 
Ever  tested for HIV 132 84.6 420 85.9  0.16 .69 
 
Note. Limited risk assessment at screening due to IRB restrictions 
a Fisher’s Exact Test 
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Multivariate Assessment of Study Enrollment 
Multivariate logistic regression analysis that included those variables significantly related 
to study enrollment in the bivariate analyses indicated that study site, race, and employment 
status were the primary factors related to study enrollment.  The adjusted odds ratios and 
associated confidence intervals are presented in Table 5. 
 
Table 5 
Factors Related to Study Enrollment: Multivariate Logistic Regression Results  
 
 
  Adjusted  
Variable Odds Ratio  95% CI 
 
Study Site  
 Kensington (reference) - - - 
 Prevention Point 0.52 0.33 – 0.84 
 ACT 1.17 0.71 – 1.95 
 
Race 
 African-American (reference) - - -  
 Latino/Hispanic 0.42 0.27 - 0.64 
 Caucasian 0.34 0.17 - 0.70 
 Other 0.25 0.50 - 1.24 
 
Primary Source of Income 
 Full time  (reference)  - - -  
 Part time 0.40  0.11 - 1.44 
 Welfare 0.31  0.10 - 0.91 
 Family/friend 0.30  0.07 - 1.25 
 Hustling 0.18 0.06 - 0.57 
 Other  0.21 0.07 - 0.63 
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Randomization Assessment 
Randomization to consumer-controlled testing or traditional counseling and testing 
resulted in nearly identical groups.  Participants randomized to the two study arms did not differ 
with regard to demographics (Table 6), sex or drug risk variables assessed at screening or 
enrollment (Tables 7/8), history of sexually transmitted infections, previous HIV testing 
experience (Table 7), or most theoretical variables (Table 9).  However, the perception that 
testing would affect personal relationships did differ by group, with the TCT group being 
somewhat more likely than those randomized to CCT to perceive that testing might negatively 
impact their personal relationships. 
38 
 
Table 6 
 
Randomization Assessment: Demographics by Study Arm 
 
  Study Arm/Testing Method 
  ______________________________ 
  Consumer-Controlled Traditional 
Variable  N|M %|SD N|M %|SD  X2|t p 
Site 
 Kensington 102 43 97 39 0.73 .70
 Prevention Point 60 25 68 27 
 ACT 77 32 84 34 
Sex 
 Male 169 70 179 72 0.19 .67 
 Female 71 30 69 28 
Race 
 African-American 109 45 125 50 1.3 .72 
 Latino/Hispanic 25 10 21 8 
 Caucasian 104 43 101 41 
 Other 2 1 2 1 
Education 
 < HS 90 38 103 41 1.11 .57 
 HS 101 42 105 42 
 College 48 20 41 17 
Primary Source of Income 
 Full time  22 9 26 11 6.6 .25 
 Part time 23 10 17 7 
 Welfare 111 46 108 44 
 Family/friend 13 5 6 2 
 Hustling 31 13 35 14 
 Other 40 17 56 23 
Income  
 Under $10,000 198 83 200 80 0.52 .47 
 ≥ $10,000  41 17 49 20 
Living Situation 
 Own House 89 38 98 40 1.68 .80 
 With friend  104 44 102 42 
 Rented Room 18 8 15 6 
 Homeless 17 7 19 8 
 Other 9 4 14 6 
Medical Insurance 
 Private health plan 6 3 8 3 3.16  .68 
 Medicaid 117 51 132 54 
 Social security disability 13 6 17 7 
 Medicare 21 9 13 5 
 Military 1 1 1 0 
 Other insurance 71 31 73 29.9 
 
Age (Mean,SD, t) 40.5 9.3 40.3 9.3 0.20 .91 
 
Beck Hoplessness Scale 
 (Mean, SD, t) 3.97 3.21 3.96 2.94 0.02 .98 
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Table 7 
Randomization Assessment: HIV Risk Factors by Study Arm (screening data) 
 
   Study Arm/Testing Method 
  ________________________________ 
  Consumer-Controlled Traditional 
Risk Factor N % N % χ2 p 
 
Drug Related Risk 
Injected drugs last 6 months 157 66 172 69 0.63  .43 
Shared (syringe, cooker, 63 26 53 21 1.67  .20 
 cotton, rinse water) 
 
Sexual Risk  
Sex with male partner 62 26 66 27 0.13  .91 
Anal Sex with male partner 11 5 17  7 0.78  .38 
Sex with female partner 151 63 169  68 1.19  .28 
STDs 
Hepatitis B/C 33 14 24  10 2.45  .29 
Gonorrheaa 4 2 0  0 4.20  .06 
Syphilisa  0 0 3  1 2.90  .25 
Ever tested for HIV 209 87 211  85 0.55  .46 
aFisher’s exact test 
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Table 8 
 
Randomization Assessment: HIV Risk Factors by Study Arm (Risk Assessment Battery) 
 
   Study Arm/Testing Method 
  ____________________________ 
  Consumer- 
  Controlled Traditional 
 
Risk Factor N|M %|SD N|M %|SD  χ2|t p 
 
Risk Assessment Battery (Mean,SD, t) 
 
 Sex Risk 4.91 3.28 5.36 2.96 1.55 .12 
 
 Drug Risk 5.91 5.81 5.69 5.98 0.41 .69 
 
 Total RAB Score 10.86 7.49 11.12 7.54 0.38 .70  
 
Drug Risk Variables  
 
 Injected in Past 6-Months  156 66 171 69 0.54 .46 
 
 Shared Needles (past 6-months) 62 26 68 27 0.12 .73 
 
 Injected Heroin (past month) 131 58 147 62 0.52 .47 
 
 Injected Cocaine (past month) 56 25 61 26 0.03 .88 
 
 Injected Amphetamine (past month) 16 7 11 5 1.33 .25 
 
Sex Risk Variables 
 
 Paid to have sex  11 5 18 7 1.54 .22 
 
 Men reporting sex with men 
 
 Sex with HIV+ partner  11 5 18 7 1.50 .22 
 
Note. Percents represent % “yes” 
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Table 9 
Randomization Assessment: Theoretical Factors by Study Arm 
___________________________________________________________________________ 
   Study Arm/Testing Method 
 _______________________ 
  Consumer- 
  Controlled Traditional 
 _________ _________ 
 
Variable M|N SD|% M|N SD|% t|χ2 p 
___________________________________________________________________________ 
 
Beck Hopelessness Scale 3.97 3.22 3.96 2.94 0.02 .98 
  
Health Belief Model 
  
 Perceived susceptibility 2.96 1.10 2.90 1.10 0.53 .59 
 
 Treatment efficacy/ Perceived severity 3.95 0.88 3.93 0.95 0.14 .89 
 
 Personal efficacy (coping) 2.66 1.29 2.62 1.29 0.34 .73 
 
Theory Reasoned Action/ 
Planned Behavior 
 
 Intentions to test (% Yes) 103 43.1 105 42.2 0.04 .84 
 in next 30 days 
 
 Perceived norms 3.45 0.77 3.43 0.81 0.01 .93 
 
 Personal health (feel good) 5.70 0.90 5.70 0.87 0.01 .99 
 
 Social consequences (stigma) 2.20 0.92 2.36 0.98 1.86 .06 
 
 Personal relationships 1.83 0.89 2.12 1.03 3.33 .001 
 
Distrust of government 2.51 1.30 2.67 1.22 1.46 .14 
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Differences among Sites/Drug Treatment Context 
Participant demographics, HIV risk factors, and theoretical measures differed 
substantially across site/treatment context.  Syringe exchange participants were more likely than 
those in detoxification or methadone maintenance to be African American, to report “hustling” as 
a primary source of income, and to report an income in excess of $10,000 per year; however, 
syringe exchange participants were also less likely to report living in their own house and more 
likely to report being homeless (Table 10).  Syringe exchange participants had higher scores on 
the RAB sex and drug risks scales, and were more likely than participants from the other sites to 
have injected drugs in the past six months including heroin, cocaine, and amphetamines; and to 
have shared injecting equipment (Table 11).  Furthermore, participants from the syringe 
exchange site were more likely than those from the other sites to have been paid for sex, to 
have had sex with a partner known to be HIV infected, and to report a recent STD (Table 12).  
Syringe exchange participants also had higher Beck Hopelessness Scale scores, perceived 
themselves more likely to become HIV infected in the future, and were more likely to report a 
recent intention to be tested for HIV (Table 13). 
Participants from the detoxification program were younger, more likely to live with a 
friend, and had lower Beck Hopelessness scores than did participants from the other sites 
(Table 10).  These participants were also somewhat less likely to report having been diagnosed 
with hepatitis B/C.  Detoxification participants had higher personal self-efficacy scores regarding 
their ability to cope with HIV infection should they test HIV antibody positive and had lower Beck 
Hopelessness Scale scores than participants from the other sites (Table 13). 
Methadone maintenance program participants were more likely than those from the 
other sites to be female, of Hispanic ethnicity, to report Welfare as their primary source of 
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income and their income to be less than $10,000 per year, and to be receiving Medicaid (Table 
10).  However, participants from the methadone program were also more likely than those from 
the other sites to report living in their own house.   With regard to HIV risk, participants from the 
methadone program had the lowest sex and drug RAB scores among the sites and were less 
likely to have injected heroin, cocaine, and amphetamines than were participants in the other 
programs (Table 11).  Furthermore, methadone participants perceived themselves to be less 
susceptible to HIV infection and were not as likely to report a recent intention to test for HIV 
antibodies than were participants from the other programs (Table 13). 
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Table 10 
Demographics by Study Site/Treatment Context 
 
   Study Site/ Drug Treatment Context 
 ______________________________________ 
  Syringe Detox  Methadone  
  Exchange  Maintenance 
Variable N|M %|SD N|M %|SD N|M %|SD χ2|F p 
Sex 
 Male 152 76 188 76 111 56 25.3 .000 
 Female 47 24 60 24 86 44 
Race 
 White 80 40 122 49 91 46 26.3 .000 
 Black 110 55 96 39 74 38 
 Hispanic 7 4 29 12 29 15 
 Other 3 2 1 0 3 2 
Education 
 <High school 44 33 80 41 69 43 5.5 .231 
 High school 59 44 86 44 61 38 
 Any College 29 15 30 23 29 18 
Primary source of income 
 Full time job 7 4 33 13 12 6 104.0 .000 
 Part time job 17 9 23 9 9 5 
 Welfare 75 38 98 40 107 54 
 Family/friend 4 2 18 7 2 1 
 Hustling 59 30 38 15 4 2 
 Other 36 18 37 15 63 32 
Income  
 Under $10,000 142 72 116 87 140 88 18.1 .000 ≥ 
$10,000 54 28 17 13 19 12 
Living Situation 
 Own House 38 29 69 39 80 50 42.4 .000 With 
friend  55 41 91 47 60 38 
 Rented Room 10 8 8 4 15 9 
 Homeless 21 16 15 8 0 0 
 Other 9 7 10 5 4 3 
Medical Insurance 
 Private health plan 8 7 2 1 4 3 108.5 .000 
 Medicaid 47 39 79 41 123 79 
 Social security disability 9 7 5 3 16 10 
 Medicare 5 4 23 12 6 4 
 Military 2 2 0 0 0 0 
 Other insurance 
 
Age (Mean,SD, F) 43.8 7.99 36.5 9.52 42.9 8.42 38.5 .000 
 Median 44.3  36.1  44.1 
 
Beck Hopelessness (M, SD,F) 4.87 3.76 3.55 2.41 3.72 3.05 8.24 .000 
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Table 11 
HIV Risk Factors (RAB data) by Study Site/Treatment Context 
 
   Drug Treatment Context 
 ________________________________ 
  Syringe Detox Methadone  
  Exchange  Maintenance 
 
Risk Factor N|M %|SD N|M %|SD N|M %|SD χ2|F p 
 
Risk Assessment Battery (M,SD,F) 
 
 Sex Risk 6.0 3.72 5.4 2.97 4.43 2.44 14.3 .000 
 
 Drug Risk 8.5 5.98 5.7 5.94 3.62 4.82 26.9 .000 
 
 Total RAB Score  14.5 8.32 11.3 7.07 7.76 5.74 32.4 .000 
 
Drug Risk Variables 
 
 Injected in Past 6-Months 114 87 118 60 94 59 32.4 .000 
 
 Shared Needles (past 6-months) 45 35 52 27 33 21 7.02 .03 
 
 Injected Heroin (past month) 103 79 103 60 71 45 34.5 .000 
 
 Injected Cocaine (past month) 55 42 43 25 19 12 34.3 .000 
 
 Injected Amphetamine (past month) 17 13 6 4 4 3 17.1 .000 
 
Sexual Risk Variables  
 
 Paid to have sex  19 15 5 3 5 3 23.3 .00 
 
 Men Reporting Sex with Men 4 12 1 5 0 0 3.4 .18 
 
 Sex with HIV+ Partner  19 15 5 3 5 3 23.3 .000 
 
Note. Percents represent % “yes” 
46 
 
Table 12 
Reported STDs and Previous HIV Testing by Study Site/Treatment Context 
 
  Site/Drug Treatment Context 
  _______________________________________ 
  Syringe Detox Methadone  
  Exchange  Maintenance 
Risk Factor N % N %  N % χ2 p 
 
STDs 
Hepatitis B/C  22 17 16 8 19 12 5.4 .07 
 
Gonorrhea  3 2 1 1 0 0 4.90 .09 
 
Syphilis  3 2 0 0 0 0 8.03 .02 
 
Any STD  
 
Ever tested for HIV 114 86 164 84 142 89 2.34 .31 
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Table 13 
Theoretical Factors by Site/Treatment Context 
 
  Study Site/Drug Treatment Context 
 ____________________________________________ 
 
  Syringe Detox Methadone  
  Exchange  Maintenance 
  _________ _________ __________ 
Variable M|N SD|% M|N SD|% M|N SD|% F|χ2 p 
 
Beck Hopelessness Scale 4.92 3.79 3.55  2.41 3.72   3.72  8.9  .000 
  
Fear Government  2.68 1.04 2.61 1.08 2.72 1.06 0.53 .59 
   
Health Belief Model 
 Perceived susceptibility 3.20 1.10 3.0 1.03 2.63 1.12 10.4 .000 
 Treatment efficacy/severity 3.92 0.87 3.92 0.97 3.99 0.92 0.35 .71 
 Personal efficacy 2.49 1.26 2.88 1.30 2.48 1.25 5.7 .004 
 
Theory Reasoned Action/ 
Planned Behavior 
 Intentions (n/%) 85 64 71 36 52 33 34 .000 
 Personal health 5.73 0.82 5.65 0.90 5.74 0.92 0.59 .56 
 Social consequences 2.32 0.98 2.23 0.99 2.31 1.01 0.46 .63 
 Personal relationships 1.88 0.87 2.09 1.01 1.93 1.01 2.28 .10 
 
Distrust of government 2.60 1.21  2.61 1.31 2.55 1.25 0.13 .88  
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Participant Retention and Attrition  
Of the 489 participants who were enrolled in the study, 417 (86%) completed their 
follow-up visit, and 71 (15%) did not return for this visit.  There was no difference in follow-up 
between participants randomized to TCT and CCT (χ2=0.21, p ≤ 0.65).  However, several 
differences were observed between participants retained and not retained in the study with 
regard to demographic, HIV risk behavior, and theoretical variables.  Participants who were not 
retained in the study were more likely to have been enrolled from the detoxification hospital, and 
less likely to report being on Welfare and to report Medicaid as their health insurance (Table 
14).  Furthermore, participants who did not return for their follow-up visit had higher RAB drug 
and total risk scores and were more likely to report recent injection of cocaine than were 
participants who were retained in the study (Table 15).   Lastly, participants who were retained 
in the study were more likely than those who were not, to report that HIV testing is perceived to 
be an important part of their personal health strategy (Table 16). 
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Table 14 
 
Retention Status by Demographic Variables 
 
   Retention Status 
  _________________________________ 
  Retained Not Retained 
Variable  N|M %|SD N|M %|SD χ2|t p 
Site 
 Kensington 152 37 49 69 32.5 .00
 Prevention Point 110 26 17 24 
 ACT 155 37 5 7 
Sex 
 Male 294 71 53 75 0.46 .49 
 Female 122 29 18 25 
Race 
 African-American 201 48 33 47 2.72 .44 
 Latino/Hispanic 42 10 4 6 
 Caucasian 170 41 34 48 
 Other 4 1 0 0 
Education 
 < HS 171 41 22 31 2.41 .49 
 HS 233 56 46 66 
 College 13 4  3 
Primary Source of Income 
 Full time  38 9 10 14 11.4 .04 
 Part time 34 8 6 9 
 Welfare 193 46 26 37 
 Family/friend 14 3 5 7 
 Hustling 51 12 15 21 
 Other 87 21 8 11 
Income 
 Under $10,000 342 82 56 79 0.40 .53 
 ≥ $10,000  75 18 15 21 
Living Situation 
 Own House 89 38 98 40 1.68 .80 
 With friend  104 44 102 42 
 Rented Room 18 8 15 6 
 Homeless 17 7 19 8 
 Other 9 4 14 6 
Medical Insurance 
 Private health plan 11 3 3 4  14.1  .02 
 Medicaid 224 55 25 37 
 Social security disability 28 7 2 3 
 Medicare 25 6 9 13 
 Military 2 1 0 0 
 Other insurance 115 28 29 43 
 
Age (Mean,SD, t) 40.8 9.35 38.9 9.61 1.80 .72 
 
Beck Hoplessness Scale 
 (Mean, SD, t) 3.94 3.11 5.58 4.09 1.64 .00 
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Table 15 
 
Retention Status by HIV Risk Variables  
 
 Retention Status 
 ____________________________ 
 Retained  Not Retained 
   
Risk Factor N|M %|SD N|M %|SD  χ2|t p 
 
Risk Assessment Battery  (M,SD, t) 
 
 Sex Risk 5.10 3.06 5.41 3.50 0.71 .48 
 
 Drug Risk 5.52 5.68 7.48 6.90 2.19 .03 
 
 Total RAB Score 10.64 7.22 13.15 8.82 2.18 .03 
 
Drug Risk Variables  
 
 Injected in Past 6-Months  277 67 49 69 0.14 .71 
 
 Shared Needles (past 6-months) 109 26 21 30 0.43 .51 
 
 Injected Heroin (past month) 233 59 44 66 1.11 .29 
 
 Injected Cocaine (past month) 93 24 24 36 4.62 .03 
 
 Injected Amphetamine (past month) 23 6 4 6 0.00 .96 
 
Sex Risk Variables 
 
 Paid to have sex  24 6 5 7 0.17 .68 
 
 Men reporting sex with men 4 6 1 17 1.11 .29 
 
 Sex with HIV+ partner  24 6 5 7 0.17 .68 
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Table 16 
Retention Status by Theoretical Variables 
   Study Arm/Testing Method 
 _____________________________ 
  Retained Not Retained 
  _________ ___________ 
 
Variable M|N SD|% M|N SD|% t|χ2 p 
 
Beck Hopelessness Scale 3.98 3.12 3.92 2.79 0.10 .92 
  
Health Belief Model 
  
 Perceived susceptibility 2.94 1.11 2.89 1.07 0.35 .73 
  
 Treatment efficacy/ Perceived severity 3.95 0.93 3.91 0.85 0.34 .74 
 
 Personal efficacy (coping) 2.64 1.29 2.65 1.29 0.05 .96 
 
Theory Reasoned Action/ 
Planned Behavior 
 
 Intentions to test (% Yes) 177 42 31 44 0.04 .85 
 in next 30 days 
 
 Perceived norms 3.46 0.80 3.35 0.75 1.08 .28 
 
 Personal health (feel good) 5.74 0.90 5.48 0.75 2.61 .01 
 
 Social consequences (stigma) 2.26 0.95 2.41 0.96 1.28 .20 
 
 Personal relationships 1.96 0.96 2.12 1.06 1.13 .19 
 
Distrust of government 2.57 1.28 2.69 1.17 0.72 .47 
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Multivariate Assessment of Study Retention 
Among those variables shown to be related to study retention in the bivariate analyses, 
only study site and RAB drug risk score retained their association in the multivariate logistic 
regression analysis. The adjusted odds ratios and associated confidence intervals are 
presented in Table 17. 
 
Table 17 
Factors Related to Study Retention: Multivariate Logistic Regression Results  
 
Variable Adjusted  
  Odds Ratio  95% CI 
 
Study Site  
 Kensington (reference) - -  - 
 Prevention Point 0.28 0.15 - 0.52 
 ACT 0.08 0.04 - 0.20 
  
RAB Drug Risk Score 1.05 1.01 - 1.10 
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HIV Testing Outcomes 
Participants randomized to consumer-controlled and traditional counseling and testing 
differed with regard to being tested while in the study (Table 18).  Participants in the CCT arm 
were 2.2 times more likely (95% CI= 1.38-3.55) than those in the TCT arm to report having 
tested for HIV antibodies at the follow-up visit.   However, no difference by study arm was 
observed with regard to receiving HIV test results or HIV antibody status. 
 
Table 18 
Testing Outcomes by Study Arm 
_____________________________________________________________________________ 
  Study Arm 
  __________________________ 
  Consumer- 
  Controlled Traditional 
  ___________ ________ 
Variable N % N %  χ2 p  
 
HIV  Testing       
 No  34 16 64 30  11.4 .001 
 Yes  174 84 147 70   
 
 
Received HIV test results 
 No  37 21 33 23  0.12 .72 
 Yes  137 79 111 77 
 
HIV serologic results 
 Negative 128 85 109 80  5.26 .15 
 Positive 6 4 8 6 
 Indeterminate 3 2 0 0 
 Don’t know 13 9 19 14 
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Bivariate Associations of HIV Testing 
Bivariate analyses of HIV testing reveled that testing differed by demographic, health 
status, HIV risk, and theoretical variables.  Demographically, testing in the study was related to 
study site, age, primary source of income, health insurance status, and a history of 
homelessness (Tables 19/20).  Testing was also associated with health-related variables 
including having had a STD or hepatitis B, reporting a recent visit to a hospital emergency room, 
or having seen a health care provider in the recent past (Table 21).  Sex and drug risk behaviors 
were also indicated by the bivariate analyses to be related to HIV testing as indicated by RAB 
scores, recent injection of drugs, the sharing of injection equipment, use of heroin and cocaine, 
being paid to have sex, and having an HIV seropositive sex partner (Table 22).  Several 
theoretical variables were also indicated to be related to HIV testing including perceived 
susceptibility/risk of HIV, perceived efficacy of available treatments for HIV infection, and recent 
intentions to test for HIV (Table 23). 
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Table 19 
Demographic Variables by Testing Outcome (1) 
 
  Testing Outcome 
  _____________________________ 
  Tested Not Tested  
Variable N|M    %|SD N|M %|SD χ2|t p 
Site 
 Prevention Point 112 35 4 4 36.4 .00 
 Kensington 99 31 49 50 
 ACT 109 34 45 46 
Sex 
 Male 225 71 70 71 0.03 .87 
 Female 94 30 28 29 
Race 
 African-American 148 46 53 54 2.82 .42 
 Latino/Hispanic 34 11 9 9 
 Caucasian 134 42 36 37  
 Other 4 1 0 0  
Education 
 <High school 125 73 47 27 2.45 .12 
 >= High school 182 78 51 22 
Primary Source of Income 
 Full time  25 8 13 13 14.4 .014 Part 
time 30 9 4 4 
 Welfare 152 485 42 43 
 Family/friend 6 2 8 8 
 Hustling 40 13 11 11 
 Other 67 21 20 20 
Income  
 Under $10,000 274 84 74 76 3.73 .053 ≥ 
$10,000 52 16 24 24    
Living Situation 
 Own House 122 38 46 48 7.31 .121 
 With friend  141 44 42 43   
 Rented Room 20 6 5 5  
 Homeless 22 7 3 3 
 Other 19 6 1 1  
Medical Insurance  
 Private health plan 9 3 2 2  1.50  .91 
 Medicaid 171 56 53 54 
 Social security disability 22 7 6 6 
 Medicare 20 7 6 6 
 Military 2 1 0 0 
 Other insurance 84 27 31 32 
 
Age (Mean,SD, t) 41.3 9.09 39.2 10.0 1.97 .05 
 
Beck Hoplessness Scale 
 (Mean, SD, t) 4.02 3.18 3.66 2.88 1.01 0.314 
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Table 20 
Demographic Variables by Testing Outcome (2) 
 
  Testing Outcome 
  _______________________________ 
  Tested Not Tested  
Variable  N    % N %  χ2 p  
 
Have Health Insurance 267 84 93 95 7.7 .006 
 
Ever Homeless 167 52 27 28 18.3 .000 
 
 
 
 
 
Table 21 
 
Health-Related Variables by Testing Outcome 
_____________________________________________________________________________ 
  HIV Testing   
  __________________________  
  Tested Not Tested  
Variable  N   % N %  χ2 p 
 
Ever STD 137 43 29 30 5.48 .019 
 
Ever Hepatitis -C 55 17 10 10 2.50 .114 
 
Ever Hepatitis B 58 18 7 7 6.84 .009 
 
Emergency Room Visit 94 29 18 18 4.63 .031 
 
Hospitalized  42 13 7 7 2.59 .11 
 
Seen Health Provider 199 62 50 51  3.89 .049 
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Table 22 
Sex and Drug Risk Variables (RAB) By Testing Outcome 
   HIV Testing  
  ____________________________  
  Tested Not Tested   
  _____________________________ 
Risk Variable N|M %|SD  N|M %|SD χ2|t p  
_____________________________________________________________________________ 
 
Risk Assessment Battery 
 
 Sex Risk 5.24 3.19 4.61 2.54 1.78 .076  
 
 Drug Risk 6.20 5.91 3.26 4.10 5.40 .000 
 
 Total RAB Score 11.47 7.60 7.87 4.96 5.30 .000  
 
Drug Risk Variables  
 
 Injected in Past 6-Months (N/%) 227 71.4 50 51.0 13.9 .000 
 
 Shared Needles (past 6-months) 93 29.2 16 16.3 6.5 .011 
 
 Injected Heroin (past month) 188 62.0 45 47.9 5.9 .015 
 
 Injected Cocaine (past month) 80 26.4 13 13.8 6.3 .012 
 
 Injected Amphetamine (past month) 21 6.9 2 2.1 3.0 .82 
 
Sex Risk Variables 
 
 Paid to have sex  24 7.6 0 0.0 7.88 .002 
 
 Men Reporting Sex with Men 9 4.0 1 1.4 1.07 .461 
 
 Sex with HIV+ Partner  24 7.6 0 0.0 7.88 .002 
_____________________________________________________________________________________ 
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Table 23 
 
Theoretical Variables by Testing Outcome 
___________________________________________________________________________ 
   HIV Testing   
  ________________________________ 
  Tested  Not Tested  
  (n=320)  (n=98)  
Theoretical Variable M|N SD|% M|N SD|% t|χ2 p 
 
Beck Hopelessness Scale 4.10 3.19 3.66 2.88 1.09 .27  
  
Fear Government  2.55 1.28 2.65 1.28 0.66 .51 
   
Health Belief Model 
 
 Perceived susceptibility 3.03 1.10 2.64 1.07 3.08 .002 
 
 Perceived treatment efficacy/severity 4.00 0.89 3.75 1.04 2.40 .02  
 
 Personal efficacy 2.65 1.28 2.60 1.31 3.32 .75 
 
Theory Reasoned Action/ 
Planned Behavior 
 
 Intentions (n|%|χ2) 157 49  20 20.4 25.2 .00  
 
 Personal health 5.77 0.87 5.66 1.01 1.02 .31 
 
 Social consequences 2.29 0.97 2.15 0.91 1.23 .22 
 
 Personal relationships 1.98 0.96 1.91 0.95 0.66 .51 
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Multivariate Analyses 
In addition to randomization to testing method (i.e., traditional counseling and testing & 
consumer-controlled testing), demographic, health status, HIV sexual and drug risk, and 
theoretical variables that were significantly related to HIV testing in the bivariate analyses were 
retained for multivariate logistic regression analyses.   Initially, hierarchical stepwise logistic 
regression was used to build a model by entering the following blocks of variables; (1) 
demographics, (2) health status, (3) HIV risk, (4) theoretical, and (5) testing method.  The 
rationale was to determine if testing method was significantly associated with HIV testing after 
accounting for the variables included in the prior steps. 
Omnibus statistics from the hierarchical logistic regression are presented in Table 24.  
Of the demographic variables shown to be related to HIV testing in the bivariate analyses, only 
study site and a previous history of homelessness were related to testing in the multivariate 
model.  Using the Cox/Snell R2, these two variables accounted for approximately 12% of the 
variance in HIV testing.  No health status variables entered in the second block were 
significantly related to HIV testing.  Of the HIV risk variables entered in block three, both the 
RAB drug risk score and a previous history of a STD were related to HIV testing, accounting for 
approximately 3% of additional variance in HIV testing beyond that of the demographic 
variables.  When theoretical variables were entered in the model, recent intentions to test for 
HIV and the perception of treatment efficacy/disease severity accounted for an additional 3.8% 
of explained variance in HIV testing.  Finally, entering testing method in the last step of the 
model accounted for an additional 2.3% of explained variance in HIV testing.  In total, the model 
accounted for 21% of the variance in HIV testing as indicated by the Cox/Snell R2. 
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Table 24 
Hierarchical Logistic Regression of HIV Testing: Reduced Model Omnibus Statistics 
___________________________________________________________________________________ 
Variable/Block Model X2 -2LL ∆-2LL Cox/Snell R2 pstep  
 
Intercept Only     412.2 
 
Block 1: Demographic Variables 
        
 Study Site 41.1 370.7 41.5 .105  .000 
     
 Ever Homeless 49.1 363.2 7.5 .123  .006 
 
Block 2: Health Status Variables -   
 No variables entered - - - -  - 
  
Block 3: HIV Risk Variables  
 
 RAB Drug Risk  55.3 356.9 6.3 .138  .012 
  
 Ever STD 60.8 352.2 4.7 .149  .030 
  
Block 4: Theoretical Variables 
  
 Intention to Test 72.8 339.3 12.9 .178  .000 
 
 Perceived Severity/Treatment Efficacy 77.1 335.1 4.2 .187  .041 
  
Block 5: Testing Method 
 
 Consumer-Controlled Testing 88.0 324.2 10.9 .210  .001  
  
 
 
The adjusted odds ratios of the independent variables associated with HIV testing in the 
multivariate model indicate that participants in the syringe exchange program were 
approximately four times more likely than those from the methadone program to be tested, 
whereas those from the detoxification program were about half as likely as participants from the 
methadone program to be tested (Table 25).  Participants who reported a history of homeless 
were almost twice as likely as those who did not, to report being tested at follow-up.  With 
regard to HIV risk, an increase of one standard deviation in the RAB drug risk score was 
associated with a 1.07 increase in the odds of testing while in the study.  Participants who 
reported having had a STD over their lifetime were twice as likely as those who did not to be 
tested.  With regard to theoretical variables, a one standard deviation increase in perceived 
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treatment efficacy was associated with a 1.35 increase in the odds of testing, and participants 
who reported a recent intention to test for HIV were almost 3 times more likely to test than 
participants who did not.  Finally, participants randomized to CCT were 2.61 times more likely to 
test than those randomized to traditional counseling and testing. 
Table 25 
Hierarchical Logistic Regression HIIV Testing: Odds Ratios and Confidence Intervals 
______________________________________________________________________________________________ 
 
Variable/Block Unadjusted   Adjusted 
  Odds Ratio  95% CI Odds Ratio 95% CI 
 
Block 1: Demographic Variables 
        
 Study Site  
  Kensington 0.83 0.51 – 1.36  0.52 0.29-0.93 
  Prevention Point 11.62 4.06 – 33.5  4.40 1.49-13.7 
  ACT (reference) - -  -  -  
 
 Ever Homeless 
 No - -  -  -  Yes
 2.89 1.76 - 4.73  1.87 1.02-3.42 
 
Block 2: Health Status Variables  
 No variables entered - -  -  -    
Block 3: HIV Risk Variables     
 RAB Drug Risk 1.13 1.07 – 1.19  1.07 1.01-1.14 
 
 Ever STD  
 No (reference) - -  -  -  Yes
 1.77 1.09 – 2.88  2.01 1.13-3.59 
 
Block 4: Theoretical Variables 
 Perceived Severity/Treatment Efficacy 1.32 1.04 – 1.67  1.35 1.02 -1.78 
 
 Intention to test in past 30 days 
  No (reference) - -   - -  
  Yes 3.78 2.21 – 6.47  2.97 1.58-5.59 
 
Block 5: Testing Method   
 Traditional Testing (reference) - -  -  - 
 Consumer-Controlled Testing 2.23 1.39 – 3.57  2.61 1.49-4.56 
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Moderators of HIV Testing 
While the initial multivariate model is informative with regard to the “main effects” related 
to HIV testing among participants in this study, it is also helpful to evaluate the potential 
moderators of testing.  Conceptually, moderators specify on whom and under what conditions 
another variable will operate to produce an outcome (Kraemer et al., 2001).  Potential 
moderators of the relationship between testing type and HIV testing in this study suggested by 
the initial multivariate analysis included study site, a history of homelessness, having had a 
STD, and reporting a recent intention to test for HIV.  Of these variables, additional analyses 
indicated that study site and a history of homelessness moderated the relationship between 
randomization to study arm (testing method) and HIV testing in this study. 
In the context of this study, an important question is whether HIV testing differed across 
study site as a function of testing method?  That is, does testing method increase the likelihood 
of testing in some drug treatment contexts, but not others?  To evaluate this question a testing 
method by study site interaction term was added to the multivariate model and this parameter 
was found to be significantly related to HIV testing (Wald = 7.33, p ≤ .026).  A plot of the site by 
testing method interaction is presented in Figure 2. 
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Figure 2.  HIV Testing by Study Site and Testing Method 
 
Figure 2 confirms that participants from the syringe exchange program were more likely 
to be tested than participants from the other sites/drug treatment contexts.  However, syringe 
exchange participants were more likely to test regardless of testing method, as were 
participants from the detoxification hospital.  Thus, CCT was associated with increased testing 
only among participants in the methadone program (Χ2=19.2, p ≤ .0001). 
Another question as to a potential moderator suggested by the results of the initial 
multivariate analysis, is whether HIV testing varied as a function of both testing method and a 
history of homelessness?  Identifying such an effect would potentially provided additional 
information as to the context and for whom CCT might be most effective.  This term approached 
significance in the multivariate model (Wald = 3.82, p ≤ .051) and given the limited sample size 
in this study is worthy of consideration.  A plot of the history of homelessness by testing method 
interaction is presented in Figure 3. 
64 
 
30
40
50
60
70
80
90
No Yes
Ever Homeless
%
 T
es
te
d
Traditional
Consumer-Controlled
  
Figure 3.  HIV Testing by History of Homelessness and Testing Method 
 
Figure 3 illustrates that persons who did not report a history of homeless and were 
randomized to the CCT group were more likely than those randomized to TCT, to report testing 
for HIV while in the study (Χ2=15.2, p ‹ .0001).   Participants who did report a history of 
homelessness were equally likely to report testing for HIV in the study regardless of testing 
method. 
Mediators of Testing Method and HIV Testing 
While the hierarchical logistic regression analysis of HIV testing presented in Tables 
24/25 is informative with regard to estimating the effect of testing method beyond that of 
demographic and theoretical variables, it does not  address the potential mediators associated 
with HIV testing.  Conceptually, a mediating variable is one that explains how or why another 
variable affects an outcome (Kraemer et al., 2001).   Similarly, in clinical trials mediators identify 
why and how treatments have effects (Kraemer, 2002). For example, variables that may not be 
directly related to HIV testing in this study, but may indirectly influence testing through their 
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associations with variables such as intentions to test, may also provide insight as to strategies 
for increasing HIV testing among persons at significant risk of HIV.   
Because behavioral intentions have been implicated as the immediate precursor to 
behavior (Ajzen, 1985; Fishbein et al., 1975), and were directly related to HIV testing in this 
study, additional analyses were conducted in order to evaluate a broader, potentially more 
comprehensive model of HIV testing that included the correlates of behavioral intentions.  
Including such variables would allow for analyses assessing behavioral intentions as a potential 
mediator associated with HIV testing.  Based upon the Health Belief Model and the Theories of 
Reasoned Action/Planned Behavior, intentions to test were regressed on drug-related risk for 
HIV, as well as perceptions of personal risk of HIV infection, treatment efficacy, personal 
efficacy to cope with HIV diagnosis, normative attitudes toward testing, benefit of regular testing, 
potential stigma, and negative reactions from others if HIV positive.   After controlling for study 
site, of these variables, perception of HIV risk (OR = 1.23, 95% CI= 1.02 - 1.48) and perceived 
benefit of regular testing (OR = 1.78, 95% CI= 1.37 - 2.24) were found to be related to a recent 
intention to test for HIV. 
When considering perception of HIV risk and perceived benefit of regular testing along 
with the variables show to be related to HIV testing in the hierarchical logistic model, at least 
one conceptual model of HIV testing can be hypothesized.  This potential conceptual model is 
presented in Figure 4 
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Figure 4.  Conceptual Model of HIV Testing 
This model illustrates the relationships observed in the initial hierarchical logistic 
regression analysis.  For example, it reflects the observed effects of intentions to test (A), drug 
risk (B), and perceived treatment efficacy on HIV testing (C).  It also incorporates the results of 
the logistic regression analysis of recent intentions to test by including an effect of the perceived 
benefit of regular HIV testing on intentions to test (D).  Furthermore, it suggests that perception 
of HIV risk potentially mediates the relationship between HIV drug risk behavior and intentions 
to test.  This relationship implies that HIV drug risk influences intentions to test via perception of 
HIV risk.  The model also suggests that intentions to test might mediate the relationships 
between the perceived benefit of testing and perceptions of HIV risk on HIV testing.   
Because the dependent variables suggested by this conceptual model (i.e., testing for 
HIV in the study and intentions to test) are dichotomous rather than continuous, it is not possible 
to estimate the direct and indirect effects of the model variables on HIV testing as might be done 
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using path analysis or structural equation modeling  (Cohen & Cohen, 1983).  However, tests for 
mediation using logistic regression analysis evaluating the dominance and codominance of 
variables as they relate to each other and the dependent variable can be conducted on each 
potential triad of variables that may include a mediating variable (Kraemer, Stice, Kazdin, 
Offord, & Kupfer, 2001; Baron & Kenny, 1986).  Given the analytic constraints associated with 
the dichotomous variables, the potential mediating relationships among variables in the 
conceptual model were identified and tested individually.   These results are presented in Figure 
5. 
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Figure 5.  Results of Mediational Analyses 
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These results indicate that intentions to test partially mediate the relationship between 
perceived risk of HIV infection and testing in the study.  Other potential mediators suggested by 
the conceptual model in Figure 4 were not confirmed in these analyses, suggesting that the 
relationships of the independent variables and the potential mediator were “overlapping factors” 
associated with a dependent variable, but not mediating factors (Kraemer et al., 2001).  
 
Satisfaction with HIV Counseling and Testing 
Participants were asked to rate the degree of satisfaction with their HIV counseling and 
testing experience in the context of this study across 16 satisfaction variables.  In general, 
participants in the CCT arm rated their testing experience more highly than those in the TCT 
arm (Table 26).  Pre- and post-test counseling, location and quality of testing, information 
provided during counseling, cost of services, and time spent waiting for results were all rated 
more favorable by CCT participants than TCT participants.  No differences between groups 
were noted with regard to the staff attitudes and concerns toward drug users, the confidential 
nature of testing, referrals, or knowledge and professionalism of the staff. 
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Table 26 
Satisfaction with HIV Counseling and Testing 
___________________________________________________________________________ 
   Testing Method   
  ________________________________ 
  CCT Traditional  
Satisfaction Variable Χ SD Χ SD t p 
 
Location of testing 4.71 .76 4.35 .96 3.57 0.000 
 
The quality of testing 4.66 .75 4.26 .97 4.03 0.000 
 
Information provided 4.62 .77 4.19 1.15 3.78 0.000 
 
Time spent  4.48 .97 3.99 1.25 3.71 0.000 
 
Staff attitude toward drug users 4.51 .86 4.30 1.17 1.59 0.113 
 
Staffs concern and care about you 4.38 1.00 4.18 1.16 1.38 0.168 
 
Cost of services 4.88 .48 4.66 .68 3.08 0.002 
 
Pre-test counseling 4.49 .85 4.14 1.04 3.04 0.003 
 
Post-test counseling 4.40 1.05 3.96 1.30 2.57 0.011 
 
Confidential nature of testing 4.77 .64 4.65 .85 1.33 0.183 
 
Time spent with you 4.47 .98 4.22 1.08 1.84 0.680 
 
Referrals provided to you 3.77 1.63 3.63 1.51 0.48 0.630 
 
Time spent waiting for results 4.33 .99 3.77 1.33 3.87 0.000 
 
Blood draw  4.11 1.16 4.22 1.12 -0.81 0.420 
 
Knowledge of staff 4.41 .99 4.31 1.11 0.77 0.440 
 
Professionalism of staff 4.58 .88 4.35 1.14 1.78 0.076 
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CHAPTER 4 
DISCUSSION 
In this study, marginalized individuals with few economic resources and a recent history 
of drug use behavior placing them at-risk of HIV infection were targeted for an evaluation study 
of different HIV testing methods.  The primary objective of the study was to determine if testing 
method (i.e., consumer-controlled testing versus traditional HIV counseling and testing) was 
associated with different rates of testing between participants randomized to the two methods of 
HIV testing.  The secondary objectives of the study were to determine for whom and under what 
conditions testing method was related to HIV testing and also to identify theoretical factors 
related to HIV testing.   Because the social, demographic, and HIV risk-related factors among 
drug users can vary greatly across prevention and treatment contexts, three study sites serving 
injecting drug users across a continuum of drug treatment participated in the study; out-of-
treatment drug users (syringe exchange program), methadone maintenance (i.e., substitution 
therapy) patients, and individuals in a hospital-based drug detoxification program. 
Factors Related to Study Enrollment  
In public health evaluation studies that employ convenience sampling it is useful to 
understand the characteristics of those who enroll in a study and those who do not, for the 
purposes of prevention research and programming planning.  In this study, differences were 
observed between individuals who enrolled in the study and those who did not with regard to 
demographic, HIV risk behavior, and theoretical variables.  Multivariate analyses indicated that 
Blacks/African Americans were more likely to enroll than were other ethnic groups. Given that 
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HIV disproportionately affects the African American community (CDC, 2000; CDC, 2004) 
their willingness to participate in public health studies such as this is encouraging, especially 
when considering reports that African Americans are less likely to participate in research studies 
in a variety of contexts (Guinan, 1993; Sengupta et al., 2000; Fullilove, 2004).  However, the 
multivariate analyses also indicated that individuals who were more likely to be marginalized, as 
indicated by a lack of employment or a lack of involvement in drug treatment, were less likely 
than more “stable” individuals to participate in the study.  This suggests that those who were 
most at-risk of HIV infection were less likely to participate in this study that could have provided 
them with an opportunity to learn their HIV serostatus, and if seropositive, to have been referred 
for medical care.  That these marginalized individuals were least likely to participate in the study 
underscores the need to develop appropriate methods to reach and engage this population.  
Furthermore, this phenomena is consistent with reports in the literature that involvement in drug 
treatment may facilitate HIV prevention efforts (Metzger & Navaline, 2003). 
However, while individuals potentially at the greatest risk of HIV infection declined to 
participate in the study, a significant majority of those who did enroll reported recent injection 
drug use and sharing of injecting equipment, indicating that whose who enrolled were at 
substantial risk of HIV infection.   Furthermore, individuals who did choose to participate in the 
study had few economic resources, little education, were unlikely to live in their own home, and 
were likely to be on welfare.  Thus, both the HIV risk behavior reported by study participants and 
their lack of economic resources suggest that this study population was both marginalized and 
at significant risk of HIV infection.   
Randomization 
The design used in this study was a randomized prospective field experiment.  
Randomized designs are considered to be optimal for evaluating the effectiveness of 
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interventions because they strengthen internal validity by establishing groups of approximately 
equal composition (Cook, 2002; Berk, 1985; Cook & Campbell, 1979).  In this study, participants 
were randomized to either TCT or CCT.  The randomization assessment indicated that the 
randomization did result in two nearly identical groups.  That is, demographic characteristics, 
HIV risk behavior, and most theoretical variables were equivalent across groups.  One 
difference between participants randomized to TCT and CCT was that those randomized to TCT 
were more likely to perceive that testing might negatively impact personal relationships.  This 
difference could have resulted in fewer individuals in the TCT group being tested for fear that 
testing would adversely impact personal relationships.  However, even when controlling for 
perceived negative impact on social relationships, participants randomized to the CCT arm of 
the study were more likely to be tested than those randomized to TCT. 
Study Attrition  
Of concern in longitudinal randomized studies is the potential for differential attrition 
across the arms of a study.  In this study differential attrition between TCT and CCT arms could 
have resulted in different testing outcomes between the two study arms when in fact no real 
difference existed.  However, there was not differential attrition between treatment arms in this 
study.   Multivariate analyses indicated that participants enrolled from the detoxification program 
were more likely to be lost to follow-up than were participants from the methadone maintenance 
or syringe exchange programs.   A differential loss to follow-up among study sites could have 
biased testing across sites, however, because there was not differential attrition by treatment 
arm, such a bias would not be expected to disproportionately influence the number of 
individuals tested in the TCT and CCT arms.   Finally, as in the evaluation of study enrollment, 
participants at greatest drug-related risk of HIV infection as indicated by the RAB drug risk 
score, were also somewhat more likely to be lost to follow-up.  However, those that were 
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retained reported substantial drug-related risk behavior with two-thirds reporting injecting drugs 
in the past six months.   
HIV Testing Outcomes 
Consumer-controlled testing (CCT) in this study was associated with increased HIV 
testing relative to traditional counseling and testing (TCT).  Furthermore, participants 
randomized to CCT were more satisfied with this testing methodology than were those 
randomized to TCT.  However, individuals in the CCT arm of the study were no more likely than 
those in the TCT arm to obtain their HIV test results.  Nonetheless, consistent with recent HIV 
prevention initiatives stressing the importance of individuals learning their HIV status (De Cock, 
Marum, & Mbori-Ngacha, 2003; Janssen et al., 2001) these data suggest that CCT could result 
in a net increase in the number of individuals at significant risk of HIV who learn their HIV status 
beyond that of traditional clinic- and provider-based HIV testing. 
However, the effect of CCT on increased HIV testing was only observed within one of 
the three HIV drug treatment environments, the methadone program, and among persons who 
did not report a history of homelessness.  These results suggest that HIV testing options beyond 
traditional HIV counseling and testing may appeal to some individuals, resulting in an increase 
in HIV testing, but may not appeal to others.  It is likely that the availability of multiple testing 
options offered outside of medical settings would have broader appeal to different groups at-risk 
of infection and would result in increased HIV testing, diagnosis, and treatment. 
While new testing technologies are now becoming available in the United States that 
provide HIV test results within minutes (CDC, 2003), these tests are currently only available in 
clinic- and service-based settings.  The reduced waiting time for one’s test result offered by 
these rapid tests may eliminate one potential barrier to HIV testing, however, nonclinic-based 
options that would allow an individual to self-test and learn their result in private, without the aid 
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of a clinician, may ameliorate additional barriers to testing.  Perhaps such an option would have 
been more appealing to those individuals at-risk of HIV infection that chose not to enroll in this 
study and reported income from sources likely to be associated with illegal activities? 
As the empowerment perspective suggests, the availability of an alternative testing 
method that allows individuals to control their own destiny and decision making, may increase 
volitional control and reduce barriers to testing.  CCT is consistent with empowerment theory 
because it offers the opportunity for self-determination.  The added ability to learn one’s own 
test result without the need for clinician involvement might also further reduce barriers to testing, 
consistent with the self-determination aspect of empowerment theory.  Such a self-testing model 
has been successful for other contexts, such as pregnancy testing.  And while some may be 
concerned with isolated self-testers not having adequate social support and counseling should 
they find that they are HIV seropositive, participants were more satisfied with the phone 
counseling offered by the Home Access Health Corporation (the manufacture of the HIV home 
testing kit used in this study) than they were with traditional counseling.  This indicates that such 
counseling strategies can be successfully delivered, however, further evaluation of such 
counseling methods for HIV seropositive individuals would be advisable. 
Theoretical Correlates to HIV Testing 
Several of the theoretically oriented variables evaluated in this study were related to HIV 
testing and may help inform strategies to increase testing among individuals at-risk of HIV 
infection.  Both the Theories of Reasoned Action and Planned Behavior assume that intentions 
are the immediate determinant of behavior (Ajzen, 1985; Fishbein et al., 1975).  Consistent with 
these theories, an intention to test for HIV in the thirty days prior to study enrollment was related 
to HIV testing in the study. 
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The conceptual model of HIV testing proposed in Figure 4 includes two predictors of 
intentions identified in this study; the belief that HIV testing is important from the perspective on 
one’s personal health care strategy, and one’s personal perception of HIV risk.  The implication 
is that if awareness as to the potential benefits of HIV testing could be increased among 
persons at-risk of HIV infection, intentions to test, and subsequent testing might increase as 
well.  Thus emphasizing testing as a personal health strategy by stressing that testing may 
reduce anxiety regarding one’s HIV status, facilitate health-protective behavior, promote early 
management of HIV infection, and result in referrals to social and peer support if needed may 
help to encourage intentions to test.  Caution is warranted however.  Serial HIV negative 
antibody test results in the context of ongoing risk behavior could reduce anxiety about HIV risk 
behavior and facilitate ongoing or perpetuate increases in the frequency of such behavior 
(MacKellar et al., 2002).   Risk reduction programs must be able to address the possibility of 
undue optimism related to repeated HIV negative test results in the context of ongoing HIV risk 
behavior.   
Perception of HIV risk was also related to intentions to test with an increase in 
perception of risk being associated with an increase in perception of HIV risk.  While actual risk 
behavior in this study was positively associated with perception of risk, individuals tend to have 
an optimistic bias that they are not at risk of a disease when in fact they are (Weinstein, 1982; 
Weinstein, 1987).  Thus, health education efforts that address HIV transmission dynamics and 
also personalize this information for their constituents so as to reduce optimistic bias regarding 
actual risk might also result in increased intentions to test for HIV.    The results of the analyses 
of intentions to test as a mediator of perceived risk and HIV testing (Figure 5) suggest that 
increasing perception of risk would have both a direct and an indirect effect on HIV testing. 
Conceptually related to the belief that testing is beneficial from an individual health 
perspective, is the perception that the available treatments for HIV are highly effective.  The 
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perception of treatment efficacy had a direct effect on HIV testing with those perceiving the 
available treatments to be efficacious being more likely to test than those who perceived 
treatments to be less efficacious or otherwise undesirable.   The implication is that if awareness 
of treatment efficacy is increased among individuals at-risk of HIV infection, testing might 
increase because of the perception that effective therapeutic agents exist.   However, a 
cautionary note is worthy of mention.  That is, such perceptions of effective therapies have been 
widely implicated as a precursor to increasing risk behavior and HIV/STD infection rates among 
MSM (Centers for Disease Control and Prevention, 1999b; Crepaz, Hart, & Marks, 2004; Fox et 
al., 2001; Mansergh, 2002; Scheer et al., 2001).   Thus, a balanced presentation of the efficacy 
of therapeutic agents along with some presentation of their disadvantages would be warranted. 
This study found that CCT increased HIV testing relative to TCT in a subgroup of 
individuals at high-risk of HIV infection due to injecting drug use and the sharing of injecting 
equipment.  Consistent with empowerment theory, the data indicated that providing HIV testing 
options that allowed marginalized individuals with few resources to control their own destiny 
resulted in health-enhancing decisions and behavior.  Also consistent with empowerment theory 
was that the observed outcomes of testing method differed by context and population 
(Zimmerman, 2000).  In addition to testing method, theoretical variables also suggested 
strategies for enhancing HIV testing among drug users such as emphasizing the specific 
benefits of testing, as well as the efficacy of available treatments for HIV, although such 
strategies must be pursued with caution.   
CCT technology as indicated by these study data potentially ameliorated barriers to 
testing that resulted in increased testing among some study participants.  However, the method 
of sample collection associated with this technology (finger stick with a lance) is difficult and 
aversive for some individuals.  The next logical step for further reducing barriers to HIV testing 
among individuals at risk of HIV infection would be to incorporate oral fluid testing in home HIV 
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test kits, and to further eliminate the need for a third party to provide results by allowing for a 
rapid HIV test result similar to that of home pregnancy testing.  This method could make 
counseling available on an as needed basis, delivered by telephone, and contingent upon the 
volitional control of the testing consumer. 
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Appendix A 
Theoretically Derived Items and Constructs 
Theory Item 
Health Belief Model 
 
Perceived Susceptibility 
 
1. There is little chance that I could be infected with HIV.  
 
2. My behavior places me at risk of getting HIV.  
 
3. My sexual behavior is risky in terms of HIV.  
 
4. I am more likely to die from violence than I am to die from 
AIDS.  
 
Treatment Effectiveness 
 
 
1. There is nothing you can do to treat HIV so why get 
tested? 
 
2. Effective drugs are now available for people infected with 
HIV.  
 
3. You can live a long time if you’re infected with HIV. 
 
4. A positive HIV test means that you don’t have long to live. 
 
Personal Efficacy 1. I wouldn’t be able to cope well if I tested HIV positive. 
 
2. If I tested HIV positive, I wouldn’t be able to handle it 
emotionally. 
 
3. My life would fall apart if I tested HIV positive. 
 
4. If I were HIV positive, there is a lot I could do to help 
myself. 
 
5. If I were HIV positive, I could cope well.  
 
Medical Care 1. I am able to get medical care when I need it. 
 
2. If I needed hospital care, I could get admitted without any 
trouble  
 
3. Sometimes I go without medical care because it is too 
expensive. 
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Theories of Reasoned Action/Planned Behavior 
 
Intentions to get tested  
1. In the past 30 days, had you made a definite 
decision to get tested for HIV? 
 
Perception of Subjective Norms 1. My close friends think that getting tested for HIV is 
important. 
 
2. Most people I know would not get tested for HIV. 
 
3. My primary partner has been tested for HIV. 
 
4. My sex partner(s) think that it is important to get 
tested for HIV.   
 
5. Most of the people I hang out with have been 
tested for HIV.  
 
Personal Health 1. Getting tested for HIV helps me to feel better 
about my health 
   
2. I would worry less about my health if I got tested 
for HIV.  
   
3. By getting tested for HIV I am doing something 
good for my health. 
   
4. HIV testing is an important part of my regular 
health care. 
 
Social Consequences -  
Stigmatization 
1. If I get tested for HIV people might think that I 
have AIDS.  
2. People in my life would leave me if I told them I 
have HIV.  
3. If I get tested for HIV people might think that I use 
drugs.   
4. If I get tested for HIV people might think that I am 
gay. 
 
Personal Relationships 1. I fear that my sex partner will leave me if I get 
tested for HIV 
 
2. I fear that I will loose my friends if I get tested for 
HIV. 
 
3. I fear that my sex partner will leave me if I test 
HIV positive.  
 
Distrust of Government 
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 1. I’m not sure that the federal government can be 
trusted. 
 
2. HIV is a man-made virus that was created to get 
rid of certain groups of people. 
 
3. Sometimes I think the government is using AIDS to kill 
off people who are not wanted by society. 
 
4. There is a cure for AIDS but the government is keeping 
it from people.  
 
 
